Quality of Life in Epilepsy: The Role of Psychological Resilience by Day, Kenny
































Submitted in Part-Fulfilment of the Doctorate in Clinical Psychology 
The University of Edinburgh 
2008 
 2  






 ……………………. (Signature) 
 3  
 
Acknowledgements ___________________________________________________ 6 
Abstract ______________________________________________________________ 7 
Chapter 1: Introduction ______________________________________________ 10 
1.1 General Introduction to Epilepsy ___________________________________ 10 
1.2 Introduction to Epilepsy ___________________________________________ 13 
1.2.1 History __________________________________________________________ 13 
1.2.2 Modern Medical Description/Definitions ______________________________ 19 
1.2.3 Epidemiology and Economics of Epilepsy _____________________________ 21 
1.2.4 Co-morbidity of Epilepsy ___________________________________________ 25 
1.2.5 Treatment of Epilepsy _____________________________________________ 36 
1.2.6 Intractable Epilepsy _______________________________________________ 42 
1.3 Quality of Life___________________________________________________ 45 
1.3.1 The History of Quality of Life in Healthcare ___________________________ 45 
1.3.2 Quality of Life in Epilepsy __________________________________________ 47 
1.4 Resilience ______________________________________________________ 62 
1.4.1 Historical Perspective ______________________________________________ 62 
1.4.2 Resilience as a concept _____________________________________________ 64 
1.4.3 Resilience across conditions and populations ___________________________ 66 
Coping _______________________________________________________________ 69 
1.4.4 Resilience and Quality of Life _______________________________________ 70 
1.5 Aims and Hypotheses _____________________________________________ 73 
1.5.1 Hypothesis 1___________________________________________________ 73 
1.5.2 Hypothesis 2___________________________________________________ 73 
1.5.3 Hypothesis 3___________________________________________________ 73 
2. Methodology _____________________________________________________ 75 
2.1 Design _________________________________________________________ 75 
2.2 Ethical Issues and Approval _______________________________________ 75 
2.3 Participants _____________________________________________________ 77 
2.4 Measures _______________________________________________________ 77 
2.4.1 The Quality of Life in Epilepsy Inventory-31 __________________________ 78 
2.4.2 The Hospital Anxiety and Depression Scale ____________________________ 79 
2.4.3 The Connor-Davidson Resilience Scale _______________________________ 80 
2.4.4 General Information Sheet _________________________________________ 81 
2.5 Site of Study ____________________________________________________ 82 
 4  
2.6 Procedure ______________________________________________________ 83 
2.7 Data Analysis ___________________________________________________ 84 
2.8 Statistical Power _________________________________________________ 85 
3.1. Demographic Variables___________________________________________ 87 
3.1.2 Exploration of the Data ____________________________________________ 89 
3.2 Hypotheses Related Data Analysis __________________________________ 90 
3.2.1 Hypothesis 1 _____________________________________________________ 90 
3.2.2 Hypothesis 2 _____________________________________________________ 90 
3.2.3 Hypothesis 3 _____________________________________________________ 92 
3.3 Exploratory Analyses _____________________________________________ 92 
3.3.1 Anxiety, Depression and Quality of Life _______________________________ 92 
3.3.2 Marital Status and Quality of Life ___________________________________ 93 
3.3.3 Education Level and Quality of Life __________________________________ 93 
3.3.4 Employment and Quality of Life _____________________________________ 93 
3.3.4 The Impact of Anxiety on Resilience and Quality of Life _________________ 94 
3.4 Summary of Results ______________________________________________ 96 
Chapter 4: Discussion _______________________________________________ 98 
4.1 Summary of the Research _________________________________________ 98 
4.2 Discussion of the Research Findings _______________________________ 100 
4.2.1 Hypothesis 1 ____________________________________________________ 100 
4.2.2 Hypothesis 2 ____________________________________________________ 102 
4.2.3 Hypothesis 3 ____________________________________________________ 104 
4.3 Explanations to Account for the Research Findings ___________________ 105 
4.3.1 Research Design _________________________________________________ 105 
4.3.2 Response Rate ___________________________________________________ 107 
4.3.3 Statistical Power _________________________________________________ 111 
4.3.4 Main Measures __________________________________________________ 113 
4.3.5 Seizure Type and Severity _________________________________________ 117 
4.3.6 Seizure Frequency _______________________________________________ 118 
4.4 Future Research and Implications _________________________________ 118 
4.4.1 Treatment in Intractable Epilepsy __________________________________ 119 
4.4.2 Clinician Knowledge of Quality of Life and Resilience in Epilepsy ________ 123 
4.4.3 Clinical Issues in the Management of Epilepsy ________________________ 124 
4.5 Summary and Conclusions __________________________________________ 125 
CHAPTER 5: REFERENCES _______________________________________ 127 
 5  
APPENDIX I _____________________________________________________ 139 
Information Sheet for Participants ______________________________________ 139 
APPENDIX II ____________________________________________________ 142 
General Information Sheet _____________________________________________ 142 
APPENDIX III ____________________________________________________ 144 
Quality of Life in Epilepsy-31 ___________________________________________ 144 
APPENDIX IV ____________________________________________________ 148 
Connor-Davidson Resilience Scale _______________________________________ 148 
APPENDIX V _____________________________________________________ 151 
Scatterplot of Relationship Between Quality of Life and Resilience ____________ 151 
APPENDIX VI ____________________________________________________ 153 
Scatterplots of the Relationships Between Resilience and Anxiety and Depression 153 
APPENDIX VII ___________________________________________________ 155 
Distributions of the main experimental measures __________________________ 155 
 
 
 6  
Acknowledgements 
 
The completion of this piece of research was in no way a solo effort. I would like to 
thank my academic supervisor, Dr Paul Morris, for his patience and hard work. His 
input into the revisions of the chapters was invaluable and he was always available 
for advice and discussion. My clinical supervisor, Penelope Fraser, provided me with 
support in assisting with my relationship with the Neurology department and was 
enthusiastic regarding the study. My colleagues in the clinical psychology 
department were a source of support and entertainment. My thanks also to Dr Emily 
Newman who contributed valuable statistical advice, and Drs Lucy Paterson and 
Fiona MacLeod who assisted with the final draft.  
 
I would also like to thank my fellow final year and flexible trainees. They allowed 
me to express my frustrations at the whole process and keep me motivated.  
 
Finally, I would like to thank my friends and of course, Hala.  





The quality of life of those with intractable epilepsy is significantly lower than that 
of the general population. Researchers have found that seizure frequency accounts 
for a statistically significant amount of the variance in levels of quality of life in 
those with epilepsy. However, not all studies have shown this effect. Psychosocial 
factors have recently received more attention and there is some evidence that they 
may provide a better account of the variance than seizure frequency. Psychological 
resilience, the ability to adapt to stressful events with good outcomes, is one area that 
has received little attention in the quality of life of adults with intractable epilepsy. 
 
Aims and Hypotheses 
 
The aim of the current study was to examine the role of resilience in quality of life in 
adults with intractable epilepsy. The first hypothesis predicted that the correlation 
between resilience and quality of life would be both significant and positive. 
Secondly, it was hypothesised that resilience would provide a better account of the 
observed variance in quality of life than seizure frequency. A further hypothesis 
predicted that resilience would show a significantly negative correlation with 
measures of anxiety and depression. 
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Methodology 
 
Postal questionnaires were presented to 223 patients with a diagnosis of epilepsy at 
their regular neurology review appointment. Exclusion criteria were; outwith the age 
range of 16-65, a diagnosis of intellectual impairment and seizure freedom for a 
period of 6 months. Measures of resilience, quality of life, seizure frequency anxiety 
and depression and several demographic variables were included. Of the 223 
individuals invited to take part in study, 60 returned the completed questionnaires.  
 
Results and Discussion 
 
Correlations indicted that levels of resilience and quality of life showed a significant 
and large, positive correlation. Multiple regression analysis indicated that a 
significant proportion of the variance in quality of life was accounted for by 
resilience. Seizure frequency did not account for a significant amount of the 
variance. Measures of anxiety and depression were also significantly negatively 
correlated with resilience. The results are discussed in terms of their impact on future 
treatment options for those with intractable epilepsy.  
 





CHAPTER 1: INTRODUCTION 
 10  
 
Chapter 1: Introduction 
 
1.1 General Introduction to Epilepsy 
 
Epilepsy is a condition often marked by distinct physical difficulties and severe 
psychosocial problems. From restrictions on driving, to the threat of sudden death 
and early mortality, the condition can be a major cause of psychological difficulties 
and increased levels of disability (Cockerell, Hart, Sander, Goodridge, Shorvon, & 
Johnson, 1994). Significant stigma is often associated with the condition, leaving 
some individuals isolated from society and unable to achieve valued goals (Jacoby, 
Gorry, Gamble & Baker, 2004).  
 
Current treatment of epilepsy is primarily medical, reliant on pharmacological 
intervention, requiring an intensive treatment regime, or on surgical resection. Such 
treatment demands commitment from the person with epilepsy, not only in adhering 
to the drug regime, but also in tolerating the often severe and potentially damaging 
side effects. For those who undergo psychosurgery, the risks inherent in the 
procedure provide a threat to their mortality, although these are often outweighed by 
the threat of death from the seizures and their sequelae. Many of those with the 
condition report that it impacts negatively on their overall quality of life both directly 
through the organic pathology and indirectly through psychosocial problems and 
stigma and the side effects of their anti-epileptic medication (Jacoby & Baker, 2008).  
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Previous research suggests that the greatest determinant of quality of life was 
absence from seizures, and there is good evidence that gaining complete seizure 
freedom can result in a return of quality of life to levels similar to those of normal 
controls (Jacoby, 2000). However, a third of those with epilepsy will be unable to 
gain adequate control over their seizures. Studies have shown that of this group, a 
sizable minority report that their overall quality of life is relatively unaffected, in 
spite of continued seizure episodes. Initial investigations suggested that seizure 
frequency might be able to account for this finding; with higher frequency equating 
to lower quality of life (Baker & Jacoby, 2002). However, the link between seizure 
frequency and quality of life has been an inconsistent finding (Jacoby & Baker, 
2008).   
 
Therefore, new discussions regarding the factors that may contribute to overall 
quality of life in treatment refractory epilepsy are required, which examine issues 
beyond that of seizure control or type. Theories concerning the psychosocial 
variables have been discussed as a possible additional factor that may explain some 
of the variance (Jacoby & Baker, 2008). Several authors have now published data 
regarding the influence of psychosocial factors in the quality of life of those with 
epilepsy, with a number of findings suggesting that these factors may actually have a 
more direct influence on quality of life, thereby providing more of an explanation of 
the variance than medical explanations alone (Szaflarski, Meckler, Privitera, & 
Szaflarski 2006).  
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The psychological characteristic of resilience is one factor that may be able to 
provide a useful contribution to the discussion. However, little research has been 
conducted into resilience in epilepsy. This is largely because of the difficulty of 
formalising a definition of resilience. However, recent work within the field of 
trauma and pain, aligned with the emergence of the positive psychology movement, 
has allowed for greater and more robust investigation into the characteristics 
associated with high levels of psychological resilience.  
 
The current study will examine the role that levels of psychological resilience play in 
the quality of life of those with intractable epilepsy. It will begin by providing an 
introduction into the field of epilepsy, discussing historical factors, incidence, 
diagnosis, mortality and associations. The literature regarding the treatment of 
epilepsy will be examined alongside the evidence regarding outcomes. The notion of 
quality of life will be highlighted at a general, theoretical level, before specific issues 
concerning quality of life in epilepsy are introduced. The historical perspective of 
psychological resilience will follow, specifically focusing on the definitions and 
experimental investigations. The possible influence of resilience on quality of life in 
epilepsy will be introduced.  The main hypotheses of the research will then be 
presented, followed  
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1.2 Introduction to Epilepsy 
 
Epilepsy is one of the most common neurological disorders, with approximately 50 
million people around the world meeting diagnostic criteria (WHO, 2001). To 
understand the condition and the associated stigma and fear that is associated with it, 
it is important to have knowledge of the historical genesis and of the more 





The early history of epilepsy is grounded, not in the realms of science, but in the 
crucible of myth and superstition. Early writings and reports from the Ancient 
Egyptian and Greco-Roman eras described epilepsy as a curse, arising from an 
individual having angered the Gods. Other popular beliefs included viewing those 
with the condition as being gifted seers, with the seizures themselves being prophetic 
in nature. Cures varied, with some espousing the virtues of sacrificial acts or prayer, 
and others believed that herbal remedies, such as mistletoe, would be the elixir to 
cure the condition (Eadie & Bladin, 2001).  
 
Hippocrates, and those writing in the Hippocratic style, were some of the first 
generation of writers to suggest that the epilepsies may not have a spiritual genesis, 
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but a physical one
1
. Writing in the 5
th
 Century BC, the essay entitled ―On The Sacred 
Disease‖ suggested that epilepsy was a disorder of the brain, with little recourse 
required to supernatural causes. Although the mechanisms of action were not 
accurate (Hippocrates believed that an imbalance of ―phlegm‖ was responsible), the 
thinking on the subject was instrumental in providing future researchers with the 
template with which to begin their investigations.  
 
With the demise of the ancient civilisations, the medical advances associated with 
that period also regressed. Although many individual medical researchers continued 
to investigate epilepsy with a physical cause in mind, the influence of the Roman 
Catholic Church and the relative lack of access to education for the masses, meant 
that The Dark Ages coincided with an increase in supernatural thinking; again 
epilepsy fell into the realms of the priests rather than the physicians (WHO, 2001). 
Seizures were linked to either a religious or demonic experience, with those afflicted 
viewed as outcasts, degenerates and in some cases labelled as witches and executed. 
Indeed, a text from the 15
th
 Century, the Malleus Maleficarum, meaning ―The 
Hammer of the Witches‖, listed epilepsy as an indicator of potential witchery and 
called for those with the condition to be cleansed through their execution (Eadie & 
Bladin, 2001).  
 
It was not until the mid-to-late 19
th
 Century that a medical formulation of epilepsy 
came back into vogue. The pioneer of this sea change was John Hughlings Jackson. 
Known as ―The Father of English Neurology‖ (Critchley & Critchley, 1998), 
                                               
1 Although Hippocrates is recognised as the father of modern medicine, other individuals were also 
noted to have had similar theories regarding epilepsy. Notably from Indian medicine, Atreya, whose 
views preceded Hippocrates by 400 years.     
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Hughlings Jackson was a consulting physician at the National Hospital for the 
Paralyzed (sic) and Epileptic in London from 1862 until his death in 1911. It is 
reported that his inspiration for investigating the true nature of epilepsy was a result 
of his wife‘s struggles and eventual death from what became known as Jackson‘s 
Epilepsy (Critchley & Critchley, 1998).  
 
Hughlings Jackson‘s work centred on the theory that the motor convulsions observed 
in patients experiencing seizures may be functionally linked to specific areas of the 
brain. Using this theory, Hughlings Jackson postulated that epileptic seizures were 
the result of sudden electrical discharges within the brain and that the site and 
character of the motor convulsions could lead to an understanding of where in the 
brain the discharges were occurring (Taylor, 1931). This was a key moment in the 
demystification of the disorder, with investigation using scientific methods now able 
to provide a more testable explanation for the mechanism behind the seizures.  
 
The German psychiatrist Hans Berger‘s observation, in 1929, that the brain‘s 
electrical activity could be recorded without the need for invasive surgical 
investigation, led to the development of the electroencephalograph (EEG). For the 
first time, physicians were able to explore the electrical profile of patient‘s brain 
activity, leading to the development of diagnostic techniques, which are still in use 
today (Temkin, 1971). This also contributed to the integration of epilepsy into the 
main body of medicine, with neurology becoming a more widespread discipline 
(Eadie & Bladin, 2001). 
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In spite of this increased understanding of the causes of epilepsy, everyday stigma 
and fear remained a reality for those with the condition. In the early 20
th
 Century 
those with regular seizures were often held under section in psychiatric hospitals and 
sanatoriums, usually in separate wards due to fears that other patients may ―catch‖ 
epilepsy. Routine sterilisations of those with epilepsy, in line with the eugenic beliefs 
that were popular at the time, were also common practice in these hospitals and those 
with the condition found integration into normal society made difficult by restricted 
access to employment and social contact (Temkin 1971).  
 
However, the discovery of a physical correlate for the seizures led researchers to 
begin to investigate ways of controlling the condition and out of this came the 
forbearers of many of the anticonvulsant drugs used today. The first successful 
anticonvulsant medications were bromine and phenobarbitone, which started being 
used in the early 20
th
 Century. However, the side effects of these drugs meant that it 
was not until the discovery of the anticonvulsant effects of phenytoin that a genuine, 
viable method of adequate seizure control was available. Merritt and Puttnam 
pioneered the use of the drug in a series of studies in the 1930‘s and it was included 
on the list of acceptable anticonvulsants in the American Medical Association‘s 
Council New and Nonofficial Remedies publication in 1939 (Shorvon, Fish, Perucca 
& Dodson, 2004). As the century continued, the discovery and development of new 
anticonvulsants continued, with the discovery of carbamazepine in the 1950‘s and 
sodium valproate in the 1960‘s. The development of pharmacological controls for 
frequent seizures can be seen to be the turning point in the demystification of 
epilepsy. By finding a physiological cause and providing an efficacious and reliable 
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solution, researchers were able to reduce some of the confusion and fear surrounding 
the condition thereby laying the foundations for improvements in the response to 
people with the condition by society.  
 
More recent developments in the history of epilepsy are notable by their focus on 
more direct treatment models. The approval of Vagus Nerve Stimulation (VNS) by 
the Federal Drug Administration in the United States provided an adjunct to 
pharmacological methods. VNS works by providing a stimulating pulse directly to 
the vagus nerve, thereby impacting directly on the areas of the brain where seizures 
may originate. The exact action of the therapeutic effect is not clear, although 
improvements in both seizure frequency and severity have been well documented 
(Shorvon, 2004).  
 
Surgical procedures in epilepsy are also a relatively new addition to the evidence 
base, although more crude methods have been used throughout history. The 
introduction of magnetic resonance imaging (MRI) coupled with the relative 
advances in the field of neurosurgery has meant that surgery has become a more 
viable option for those whose seizures are not well controlled by anticonvulsant 
medication (NICE, 2004). Although the risks inherent to any type of surgery are well 
known, there does appear to be a significant reduction in seizures in a high 
percentage of those who undertake the procedure (Shorvon et al., 2004).  
 
Psychological approaches to epilepsy have also developed in more recent times. 
Their focus has largely been based around a cognitive behavioural approach to 
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reduce seizure frequency by addressing the internal precipitants that may contribute 
to seizure onset (Ramaratnam, Baker & Goldstein, 2005). Psychological approaches 
have also been used to improve quality of life and to assist individuals in dealing 
with the emotional sequelae of living with a chronic health condition. However, 
evidence in support of the effectiveness of these approaches is limited at best, and 
further research with more quality trials is required (Ramaratnam, Baker & 
Goldstein, 2005).  
 
Associated with this increased focus on the psychological factors in epilepsy, is a 
greater focus on the less clinical aspects of the condition. An increasing number of 
interventions have been developed to assist people with the condition to address 
areas of difficulty beyond the scope of their illness. The NICE guidelines advocate 
this approach through the greater use of the specialist epilepsy nurse and the 
provision of services other than neurology (NICE, 2004). General practitioners in the 
UK are also being encouraged to assist in the screening of those people with epilepsy 
who are maintained in primary care for psychological difficulties (NICE, 2004).  
 
Given the prolonged history of the condition, it is interesting to note that epilepsy is 
still relatively misunderstood by the population at large (NICE, 2004). The historical 
beliefs, whilst largely erroneous, have been pervasive enough to continue to have 
some influence in our apparently enlightened age. This can mean that the individual 
with epilepsy is faced with the daunting prospect of facing up to a potentially chronic 
and fatal condition, with the added pressure of functioning in a society that can view 
them with suspicion.  
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1.2.2 Modern Medical Description/Definitions 
 
Epilepsy is a condition characterised by recurrent (two or more) epileptic seizures, 
unprovoked by any immediate identified cause. Multiple seizures occurring in a 24-
hour period are considered a single event. An episode of status epilepticus is 
considered a single event. Those who have had only febrile seizures (seizures in 
childhood as a result of a fever) or only neonatal seizures (seizures in the first 28 
days following birth) are excluded from this category (Commission on Classification 
and Terminology of the International League Against Epilepsy, 1993). 
 
The Scottish Intercollegiate Guidance Network (SIGN, 2003) provides guidance as 
to how epilepsy should be classified. In line with international systems of 
classification, SIGN suggest that epilepsy can be classified into three main 
categories; Partial Seizures, Generalised Seizures and Unclassified Epileptic 
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1. Partial Seizures 2. Generalised Seizures 
Convulsive or non-
convulsive with bi-lateral 
discharges involving sub-
cortical structures 
3. Unclassified Epileptic 
Seizures 
A. Simple partial seizures 
(no loss of consciousness) 










C. Partial seizures evolving 
to generalised tonic-clonic 









Seizures recorded as 
epileptic in nature but not 
described by the other 
definitions 
Table 1: Classification of Epilepsies (adapted from Diagnosis and Management 
of Epilepsy in Adults, SIGN, 2003) 
 
In summary, epilepsy is best viewed as a condition that is symptomatic of another 
underlying condition, rather than as a disease entity in its own right. The diagnosis of 
epilepsy is a complicated process and is reliant on self-report, witness observation, 
EEG, close ward based observations, induction of the seizures through sleep 
prevention or functional MRI. SIGN (2003) suggests that the most important factors 
in the attainment of an accurate diagnosis are a clear patient history and eyewitness 
information. 
 
The difficulties in diagnosing epilepsy definitively mean that the condition can often 
go undiagnosed. Differential diagnostic issues are abundant and Shorvon et al. 
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(2004) estimate that up to 30% of those with a diagnosis of epilepsy will have a 
further diagnosis. Conditions such as syncope, fatigue, non-epileptic seizures, 
anxiety and panic, can all present in similar ways to true epilepsy. As with the SIGN 
guidance, Shorvon et al. (2004) advocate an extensive investigation of all the factors 
surrounding the seizures before any diagnostic label is given. His reasoning behind 
this is not only to ensure that the patient receives the appropriate treatment, but also 
because the impact of a diagnosis of epilepsy can be detrimental to the person‘s 
overall life.  
 
1.2.3 Epidemiology and Economics of Epilepsy 
 
The reliance on observations and lack of a specific diagnostic marker can mean that 
accurate estimates of the incidence or prevalence of epilepsy are difficult to obtain. 
Sander and Shorvon (1996) consider that the current classifications are unsuitable for 
epidemiological purposes, due to the subjective nature of the diagnosis, the potential 
confounds of non-epileptic activity and confusion in the use of terminology. 
 
The heterogeneity of the disorder means that it is difficult to understand the true 
epidemiology of the condition. The most common difficulties in estimating the 
prevalence and incidence of the condition lie in the areas of diagnostic accuracy and 
case ascertainment. Sander & Shorvon (1996) state that the difficulties in diagnosing 
epilepsy to the exclusion of other conditions mean that there are likely false positive 
and false negative effects in any epidemiological study of epilepsy.  
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However, given these noted difficulties, there are many studies that have attempted 
to understand the frequency of epilepsy within populations.  
 
In Europe, Forsgren, Beghi, Oun & Sillanpaa (2005) conducted a systematic review 
of epidemiological studies from states within the European Union. In studies 
involving adults, they found a prevalence rate in the range of 5.3-6.3 per 1000 
(median 5.5), with an overall all ages prevalence of 3.3-7.8 (median 5.2). The study 
also calculated incidence rates, with the three adult studies reviewed providing rates 
of 24, 56 & 35 per 100,000 person years. Overall the study suggested that given the 
difficulties observed with case ascertainment, an overall prevalence rate 6/1000 and 
an incidence of 50-55 per 100,000 person years could be estimated.  
 
In Asia, Mac, Tran, Quert, Odermatt, Preux & Tan (2007) report a similar systematic 
review to Forsgren et al. (2005). They found a varied prevalence rate with a range 
between 1.5-14.0 per 1000 (median 6) and incidence rates of studies in China and 
India of 28.8-35 per 100,000 and 38-60 per 100,000 respectively. The authors noted 
a number of difficulties with the data, namely the use of differing diagnostic 
techniques across countries as well as the cultural attributions made towards people 
with a disability, possibly leading to a larger unknown number of people with the 
condition.  
 
In the United States two studies by Hauser, Annegers & Kurland (1991 & 1993) 
provided estimates of the prevalence and incidence of epilepsy in America. Their 
studies found prevalence rates of 6.8 per 1000 of population and an incidence of 
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approximately 44 per 100,000 person years. Both studies were limited to one 
geographic area, meaning that there may be further geographic and cultural 
variations throughout the rest of the United States.  
 
Studies from the African continent are less common, but Preux and Druet-Carbanac 
(2005) examined the prevalence and incidence of epilepsy in sub-Saharan Africa. 
The authors found prevalence rates discovered in door-to-door studies of a range of 
11.8-20.4 per 1000 (median 15) and an incidence in the range of 63-158 per 100,000 
person years. Again, methodological difficulties were noted in the areas of diagnosis, 
local knowledge and geo-cultural variation.  
 
Within the UK, the prevalence and incidence is similar to that of Europe as a whole. 
MacDonald, Cockerell, Sander & Shorvon (2000) examined the incidence and 
prevalence of neurological disorders across a sample of English GP practices. They 
found a prevalence rate of 4 per 1000 and an incidence of 46 per 100,000 person 
years. In 1997, the Clinical Standards Advisory Group (CSAG, 2000) was instructed 
by the health minister to investigate the services for people with epilepsy. Their 
report also indicated that the reported prevalence within the UK of epilepsy was 
approximately 5-10 per 1000 and the incidence may be as high as 80 per 100,000 
person years. Similarly, the NICE Guideline ―The epilepsies: the diagnosis and 
management of the epilepsies in adults and children in primary and secondary care‖ 
published in 2004, indicated figures based on both the MacDonald et al (2000) and 
CSAG studies. There are no specific published results for the prevalence or incidence 
rates for Scotland rather than the UK, although it could be assumed that these would 
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be similar to those conducted in England given the geographical and cultural 
proximity. 
 
Within the epidemiological data, there are a number of trends. Age differences are 
noted within the two main systematic reviews (Mac et al, 2007; Forsgren et al, 2005) 
with most studies reviewed suggesting that the peak ages for prevalence is childhood 
or young adulthood and the elderly. Gender differences (males > females) are also 
noted, but in most studies reviewed these differences are not significant. In terms of 
types of epilepsy, the systematic reviews suggest that the most common are partial 
seizures rather than generalised seizures, although Forsgren et al. (2005) do note that 
up to 20% of epilepsies are unclassifiable.  
 
The overall prevalence and incidence of the epilepsies in a Western population can 
therefore be estimated to lie somewhere in the region of 5-15 per 1000 and 25-80 per 
100,000 patient years.  
 
The economic impact of the epilepsies has also been extensively investigated. 
Pugliatti, Beghi, Forsgren, Ekman & Sobocki (2007) examined the health economics 
of the epilepsies across the 25 European Union member states in addition to Iceland, 
Norway and Switzerland. They examined the reports from all the states regarding 
epidemiology and cost of illness and extrapolated these results to fit into a model of 
cost for the year 2004. They estimated that for a population of 3.4 million Europeans 
with epilepsy, the cost of treating the disease was 15.5 billion Euros per annum. 
Indirect costs made up the majority of this figure through working hours lost and 
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premature death. Direct healthcare costs approximated 2.8 billion Euros, and direct 
non-healthcare costs (such as social services or home adaptations) contributed 4.2 
billion Euros per annum. The study unfortunately did not examine the cost of the 
psychological impact of epilepsy, though the authors expected this figure to be 
substantial.  
 
Since epilepsy can be regarded as the most common neurological condition in the 
medical world, and its effects have an impact both on a societal and individual level, 
any interventions that could assist in the management of the condition and reducing 




1.2.4 Co-morbidity of Epilepsy 
 
Epilepsy is often associated in the published literature with other health conditions. 
In theory, this is unsurprising given that the epileptic activity will often be secondary 
to the presence of conditions such as brain damage. However, there is good evidence 
that psychiatric difficulties can also occur at a higher rate in people with epilepsy 
than they would in the general population. Gaitatzis, Carroll, Majeed & Sander 
(2004) examined the rates of somatic and psychiatric diagnoses amongst a population 
of people with epilepsy and found that 41% received a psychiatric diagnosis during 
their three-year study period. Given this high prevalence rate, it is important to 
understand which conditions may be more likely in those with epilepsy and also to 
explain some of the reasons behind this apparent elevated risk.  




The co-morbidity of anxiety disorders and epilepsy is well documented. Gaitatzis 
and colleagues (2004) found that 15% of their sample received a diagnosis of 
neurosis and 11% receiving a diagnosis of anxiety during a three year period.  
 
Piazzini, Canevini, Marggiori & Canger (2001) examined 150 patients with partial 
epilepsy, 70 individuals with idiopathic generalised epilepsy and a control group 
(n=100). Levels of anxiety were assessed using the State-Trait Anxiety Inventory 
Scale (STAI-S, Speilberger, 1967). The results indicated that the epilepsy group 
displayed significantly higher levels of anxiety than the controls. The group with 
partial seizures were also significantly more anxious than those with idiopathic 
generalised seizures. Within the partial epilepsy experimental group, patients with 
Temporal Lobe Epilepsy displayed significantly higher levels of anxiety than those 
with frontal lobe epilepsy. No significant relationships were found between anxiety 
and either seizure frequency or the time since the onset of epilepsy. The authors 
concluded from the results that anxiety disorders are more likely to be a 
manifestation of specific changes in brain function, rather than as a reaction to the 
stigma of having or the difficulties in coping with epilepsy. Although the design of 
the study was robust, patients who were currently on medication other than anti-
convulsants (such as anti-depressants or anti-anxiolytics) were excluded. This may 
have served to dilute the true level of anxiety amongst the population of people with 
epilepsy.  
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An important delineation when discussing the link between epilepsy and anxiety is to 
differentiate between what can be regarded as normative levels of fear or anticipatory 
anxiety, and what is an excessive or phobic reaction. This is highlighted by Baker 
(1997) who states, 
 
―..although many patients are fearful of their seizures, only a relatively small 
number develop a true phobic anxiety‖ Baker, 1997 p98.  
 
Baker goes on to provide a description of how anxiety may come about as a result of 
epilepsy. He states that on one level there is the fear about the potential to have a 
seizure. This can be regarded as a general level of fear or anxiety, which will be 
affected by individual characteristics. This general anxiety can lead to appraisals 
concerning the possibility of death or injury as a result of the seizure. A further 
concern resulting from the fear of having a seizure is the possibility of stigmatisation 
resulting from being observed to have seizure. Both these direct and indirect fears, or 
threats to self, can feedback into the general fears, resulting in a degree of 
hypervigilance or hyperarousal. The hypervigilance can lead to negative appraisals 
and the hyperarousal could lead to a lowered threshold for a seizure.  This 



























Figure 1: Anxiety model in epilepsy, based on Baker, 1997 
 
Whatever the mechanism, the observation that those with epilepsy are at increased 
risk of experiencing anxiety disorders is one that requires consideration when 
professionals are working closely with those with the condition. This is important as 
although anxiety itself may or may not have an influence on the occurrence of 
seizures, it may have an impact on the person‘s overall level of wellbeing and 
functioning.  
 
Depression and Suicidality 
 
The prevalence of depression in those with epilepsy is much higher than that found 
in the general population. Harden (2002) estimates that depression is much more 
common in people with epilepsy than those in the general population, with a range of 
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The relationship between depression and the intractability of seizures has been 
investigated by Attarian and colleagues (Attarian, Vahle, Carter, Hykes & Gilliam, 
2003).  Using a cut-off on the Beck Depression Inventory-Second Edition (BDI-II, 
Beck, Steer & Brown, 1996) of 16 to indicate depression, the authors found that from 
61 individuals with intractable epilepsy (defined as patients who had had seizures 
within a 6 month period and had already been on 2 or more anti-epileptic 
medications), 10 % displayed scores on the BDI-II associated with a diagnosis of 
depression. For those with well-controlled epilepsy
 
(Defined as being seizure free for 
a period of 6 months or longer), 11% displayed symptomatic scores on the BDI-II. 
Analysis showed that there were no significant differences between the groups on 
measures of depression. Correlation analysis indicated that there was no relationship 
between seizure frequency and depression.  
 
It should be noted that although this study produced useful data, they should be 
interpreted with caution. A low n, coupled with the use of a restricted range of 
measures, without a clinically based diagnosis, meant that factors such as patient 
perceived severity of the seizures and coping style were not included in the analysis. 
Also the use of the BDI-II may also have been a potential confound due to its 
emphasis on the physical indicators of depression, which may be attributable to the 
effects of epilepsy rather than true depression.  
 
The results of Attarian et al. (2003) are useful in understanding the difficult nature of 
describing the mechanisms of depression in those with epilepsy. Intuitively, the 
effect of seizure frequency would appear to make sense; the higher level of intrusion 
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of the condition into one‘s world could lead to feelings of stigma, loss of control and 
ultimately depression. However, the relative lack of an effect indicates that perhaps 
alternative factors are implicated. Harden (2002), claims that it may be that the 
seizures themselves protect against depression through a crude form of 
electroconvulsive therapy, and provides evidence for this from a study by Robertson, 
Trimble & Townsend (1987) that reported a decrease in seizure frequency prior to 
the onset of depression. However, this study showed a number of methodological 
weaknesses, in particular a small sample size and inconsistent recording of seizure 
frequency.  
 
One area where depression can be linked directly to the condition itself is peri-ictal 
depression. Occurring in less than 1% of patients with epilepsy, it presents as 
feelings of sadness and futility during the onset, duration or sequelae of the seizure 
itself (Aldenkamp & Hendriks, 2000). Patients often cite this change in mood as part 
of the aura that indicates the possibility of a seizure occurring (Kanner, 2003). 
Although the presence of peri-ictal depression has been linked to the changes in 
neurotransmitter functioning brought on by the occurrence of seizure activity, little is 
actually known about the mechanism of peri-ictal depression (Kanner, 2003) 
 
Sleep disorders have been implicated as a possible factor in depression in epilepsy. 
Alanis-Guevara, Pen˜a,, Corona, Lo´pez-Ayala, Lo´pez-Meza. & Lo´pez-Go´mez, 
(2005) investigated the link between epilepsy and sleep disorder and found that in 
their sample, sleep disorders provided a significant proportion of the variance of 
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quality of life and depression in the final regression analysis. Part of this association 
may also be the impact that depression is known to have on sleep.  
 
Genetic factors have received some attention in the aetiology of depression in 
epilepsy. Whilst a number of studies have indicated a higher rate of familial 
psychopathology in those with epilepsy and depression (Robertson et al. 1987), 
others have found levels similar to those within the general population (Robertson, 
Channon & Baker, 1994).  
 
Suicidality in people with epilepsy has received a significant amount of attention 
within the literature. Whilst figures have fluctuated as treatments have improved 
(Blumer, Montouris, Davies, Wyler, Phillips & Hermann, 2002), there does seem to 
be an inflated risk of death through self-harm within this population. In a review of 
the literature, Matthews & Barbaras (1981) estimate that approximately 5% of people 
with epilepsy will die as a result of suicide compared to 1% of the general 
population.  
 
Blumer et al. (2002) investigated the mechanisms that may contribute to the reported 
higher levels of suicidal behaviour and suicidality within the epilepsy population. 
They investigated a sample of 10739 patients in the United States over a 12-year 
period. During this period, 5 patients died as a result of suicide. Areas of 
commonality between the successful completers were, early age of onset, presence of 
complex partial seizures and high seizure frequency. Interestingly, the suicidal act 
occurred after a period of full seizure control through psychosurgery, vagus nerve 
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stimulation or medication. The authors felt that the psychosocial correlates were of 
little import in the overall contribution to the suicide, and that post/inter ictal 
psychopathology played a larger role. However, given the limited number of 
observed suicides in this study, it would be difficult to generalise these findings. The 
authors did note that the rate of suicide in their population was significantly lower 
than would normally be expected. They felt that the use of psychopharmacological 
measures in their sample was the main preventative factor in accounting for this 
lower rate.  
 
Christensen, Vestergaard, Mortensen, Sidenius & Agerbo (2007) examined the risk 
of suicide in those with epilepsy. They investigated the association between epilepsy 
and suicide, with psychiatric diagnosis, socio-demographic factors and 
socioeconomic factors included in the analysis. Using a population sample, they 
found that the highest risk of suicide could be found amongst those who were newly 
diagnosed (defined as within 6 months of diagnosis) and who had a co-morbid 
psychiatric diagnosis. However, their analysis of this data also indicated that there is 
an increased risk of suicide in those with epilepsy even after psychiatric diagnosis 
was controlled for. The authors concluded that the pathology of epilepsy itself may 
increase the risk of suicide, independent of depression or anxiety.  
 
The information presented above indicates that depression is more common in those 
with epilepsy than those in the general population. Although there is some 
disagreement regarding the mechanisms that lead to this increased risk, it is apparent 
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that this population is in need of greater psychological and practical support beyond 
that of controlling seizures.  
 
 
Mortality, Illness and Sudden Unexpected Death in Epilepsy  
 
People with epilepsy are at greater risk of early death than the general population 
(Yuen, Thompson, Flugel, Bell & Sander, 2007; Baker & Jacoby, 2007). Yuen et al 
(2007) report that the standardised mortality ratio for people with epilepsy usually 
lies between 2-3, although they do suggest that this figure can be as high as 4.1. 
Therefore, it would appear that individuals with epilepsy are 2-4 times more likely to 
experience premature death than an age/gender matched general population. This 
would mean that approximately 50-75% of the deaths in those with epilepsy arise 
from factors associated with the condition.  
 
As well as the psychiatric co-morbidities noted within this chapter, other health 
conditions also occur at an increased level within the epilepsy population. One 
examination of the higher levels of physical co-morbidity indicated that people with 
epilepsy were at much greater risk of being diagnosed with dementias (such as 
Alzheimer‘s type), cancers, cardiovascular diseases and lung disease (Gaitatzis, et 
al., 2004). This in turn would increase the likelihood of premature death within this 
population.  
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A further area of discussion concerns sudden unexpected death in epilepsy (SUDEP). 
Annegers & Coan (1999) estimate that 20% of deaths in those with epilepsy could be 
as a result of SUDEP. Risk factors for SUDEP are acquired epilepsy arising from 
traumatic brain injury, intractability of the condition and possibly seizure severity 





The reported link between the psychoses and epilepsy has troubled and intrigued 
researchers for many years (Toone, 2000). The belief within the field is that epilepsy 
acts as a risk factor for psychosis in the interictal stage, in particular a condition 
known as schizophrenia-like psychoses (SPLE). This presents, as the name would 
suggest, in a manner similar to the delusions associated with schizophrenia. 
 
The published literature concerning the co-morbidity of epilepsy and psychosis is 
fraught with methodological difficulties. However, there does appear to be evidence 
that those with epilepsy have significantly higher levels of psychosis than chronically 
ill controls (Whitman, Hermann & Gordon, 1984). Toone (2000) suggests that there 
is a possibility that temporal lobe epilepsy may be associated with the development 
of psychosis, but there may also be a link with the age at which the individual‘s 
epilepsy first presented.  
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Toone presents two possible explanations as to the aetiology of psychosis in epilepsy 
(2000). A shared cerebral explanation for both the psychosis and the epilepsy, such 
as has been suggested in temporal lobe epilepsy is regarded as the most likely. In this 
theory, the cause of the epilepsy, either through a lesion or a tumour, also results in 
the development of psychotic symptoms. His second explanation suggests that 
seizure activity itself could result in the development of psychosis. However, he 
reports that neither of these theories has received substantial backing within the 
literature and concedes that, as with psychosis in the general population, the likely 




In the introduction to a special issue of Epilepsy and Behavior Albert Aldenkamp, 
Gus Baker and Kim Meador discuss the important multifactor causation of the 
cognitive impairments observed in those with epilepsy (2004). They argue that there 
are three important factors implicated in cognitive impairments associated with the 
condition. Firstly, the aetiology of the condition is important, as the structural 
difficulties that may be causing the seizures may also impact on an individual‘s 
cognitive functioning. Secondly, the seizures themselves can often lead to discreet or 
widespread damage to the brain. This specifically refers to the condition known as 
transitory cognitive impairment, a process by which a seizure may not noticed, but is 
marked by its symptoms of cognitive impairment (Baker & Jacoby, 2000) Finally, 
the side effects associated with treatment, be they pharmacological or surgical can 
also cause and contribute to the degree of cognitive impairment. To these three a 
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fourth could be added; the difficulties in managing the detrimental effects on 
employment and social opportunity associated with epilepsy. The relative lack of 
employment and the difficulties in maintaining or initiating positive social 
interaction may further contribute to cognitive impairment due to lack of opportunity 
to develop cognitive skills or through lack of stimulation.  
 
Given the multiple co-morbidities apparent in those with epilepsy, it is important for 
both clinicians and researchers to be aware of the potential confounding and 
complicating factors that will be apparent in those with the condition. As will be 
discussed further within this chapter, people with epilepsy face many more 
challenges beyond the difficulties of experiencing seizures (Camfield, 2007).  
 




The historical discovery of the anti-convulsant medications used in regular clinical 
practice in western medicine is detailed above. Current practice in the United 
Kingdom advocates the use of anti-convulsant medications as a front line treatment 
in reducing seizure frequency following a diagnosis (NICE, 2004). Initial 
recommended treatment is for the older anti-convulsants (sodium valproate or 
carbamazepine) to be prescribed in the first instance, unless there are significant 
contraindications. Should this be the case, the guidance recommends the use of the 
newer classes of medication (i.e.gabapentin). Initially treatment should be continued 
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on a monotherapy basis, although polypharmacy can be deemed appropriate in 
individuals with intractable seizures.  
 
The efficacy of pharmacological treatments of epilepsy is well established. In a 
descriptive study, Moran, Poole, Bell, Solomon, Kendall, McCarthy, McCormick, 
Mashef, Sander & Shorvon (2004), investigated the pattern of anti-convulsant drug 
use amongst a sample of 1652 people with a diagnosis of epilepsy. By means of a 
postal questionnaire, they found that the majority of their sample where on a 
monatherapeutic regime (68%). Carbamazepine, sodium valproate and phenytoin 
were the most commonly prescribed medications. Interestingly, 1.5% of the sample 
was not currently taking any anti-convulsant medication, which could be interpreted 
as a possible indication of non-adherence.  
 
Adherence problems are common in chronic illnesses and epilepsy does not buck this 
trend (Jones, Butler, Thomas, Peveler, & Prevett, 2006; Buck, Jacoby, Baker & 
Chadwick, 1997). Leppik (1990) reports non-adherence rates of approximately 30-
50% in a sample of patients with diagnosed epilepsy. The NICE guidelines for the 
management of epilepsy in children and adults (2004) present a number of factors 
associated with adherence rates (Table 2). Given that diminished life experiences 
appear to be linked to poorer adherence, it could be that improvements in quality of 
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Good Adherence Poorer Adherence 
Aged over 60 years 
Aged over 19 years 
Once-daily dose 
Feeling that it is important to take 
medication as prescribed 
Finding the GP easy to talk to 
Concerned about health or health risks 
Absence of barriers, such as costs 
 
Aged under 60 
Teenager (aged under 19 years) 
Four-times daily dose 
Feeling stigmatized 
Experience of side effects 
Inability to obtain medication 
Diminished life experience 
 





Psychological treatment of epilepsy has developed over many years and is now a 
common adjunct to treatment through medical techniques (Cull & Goldstein, 1997). 
The type of interventions reported are twofold; those which are aimed at the co-
morbid disorders experienced by those with epilepsy and those aimed at disease 
specific areas such as seizure frequency.  
 
Spector, Tranah, Cull & Goldstein (1999) investigated the effect of a group 
intervention using psychological approaches in reducing seizure frequency.  Nine 
patients with intractable epilepsy were assessed regarding levels of anxiety and 
depression, social avoidance and distress, self-esteem and seizure frequency. 
Treatment consisted of eight, two hour sessions focussing on areas such as 
identifying triggers, dealing with stress and coping with negative emotions. The 
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results indicated that all of the participants who attended the group experienced a 
statistically significant reduction in seizure frequency, with an average reduction of 
74%. The study was limited in terms of the number of participants, 2 of whom 
dropped out of treatment and were not included in the analysis. Furthermore, the lack 
of a control group makes it difficult to state that the noted improvements are directly 
attributable to the intervention.  
 
In 2005, Ramaratnam, et al. (2005) conducted a systematic review of psychological 
treatments for epilepsy. They reported that the significant methodological 
deficiencies within the majority of the studies reviewed mean that the results of these 
studies cannot be considered valid. In those studies where the methodology was 
rigorous enough to be included in the review, the authors considered that relaxation 
therapy may provide a degree of benefit for seizure control. However, given the 
limitations of the studies reviewed, they were unable to make any conclusions 
regarding the efficacy of cognitive behavioural therapies in the treatment of seizures.   
 
One area that has shown some promise in the psychological treatment of epilepsy is 
Acceptance and Commitment Therapy (ACT). ACT is based on the premise that 
individuals who avoid their experiences and cognitions in relation to their distress, 
are less likely to be able to cope with their difficulties. ACT concentrates on assisting 
individuals to begin to become more flexible regarding their symptoms and to choose 
solutions or behaviours that can provide them with the opportunity to successfully 
negotiate their experience (Hayes, Strosahl & Wilson, 1999). A recent study 
(Lundgren, Dahl, Melin & Kies, 2006) examined the effectiveness of ACT in a 
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population with intractable epilepsy. Using a randomised controlled design, 
participants were placed in either an ACT or supportive therapy group. The study 
aimed to examine outcomes including levels of quality of life and seizure frequency. 
The results indicated significant improvements for both quality of life and seizure 
frequency in the ACT group both at post-treatment and follow up. This suggests that 





Surgery for epilepsy may appear to be a relatively new procedure, but the first 
procedures for relieving the symptoms were recorded in the middle ages, albeit with 
a view to allowing the ‗humours and vapours‘ to leave the skull and relieve the 
patient from a demonic possession (Lüders & Comair, 2001). It was not until the late 
19
th
 Century that a more scientific approach was applied to the psychosurgery of 
epilepsy. Applied specifically to Jacksonian seizures (those with an identifiable 
lesion or injury site), these procedures involved the removal of a small circular piece 
of the skull in order to relieve pressure on the affected area of the cortex (known as 
trephination). Luders & Comair (2001) report that although these procedures 
produced reasonable success rates, the introduction of anti-convulsants meant that 
surgical options for the treatment of epilepsy were largely ignored for the first half of 
the 20
th
 Century.  
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It was not until the 1940‘s that a resurgence in the surgical treatment of epilepsy 
occurred. However, limitations in brain imaging meant that it has only been in the 
last 20 years that surgery for epilepsy has become a more accessible procedure for 
those with the condition.  
Surgery for epilepsy is often viewed as a radical and risky last resort (Wiebe, Blume, 
Girvin, Eliasziw, 2001). The NICE guidelines (2004) recommend that surgery should 
be provided as a tertiary care service following failure to gain adequate seizure 
control through the use of pharmacological methods for a period of two years and the 
use of at least two types of anti-convulsant medication. However, the guidelines state 
that epilepsy surgery is superior to long-term medical treatment in temporal lobe 
epilepsy. Although few robust studies exist, Weibe et al. (2001) report that 58% of 
their temporal lobe epilepsy sample were free from seizures impairing awareness 
compared to 8% in a matched medical sample. The authors reported that epilepsy 
surgery, where indicated, should not be viewed as a final intervention but as a 
primary treatment option.  
A more recent addition to the treatment of epilepsy arose following the approval by 
the American Food and Drug Administration of a technique known as Vagus Nerve 
Stimulation (VNS).  Although a full technical review of the procedure lies outwith 
the scope of this study, the technique appears to produce an effect through its impact 
on areas of the brain and central nervous. However, the exact mechanism of why it 
may have anti-epileptic utility is still not understood (Rutecki, 1990). The 
effectiveness of the treatment appears to be similar to that of the newer antiepileptic 
medications, although consistent results have not been found and further studies are 
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indicated (NICE, 2004). The NICE guidelines currently recommend that VNS be 
used as an adjunct to treatment in those who are not suitable for psychosurgery. 
Current treatments for epilepsy are very much focussed on gaining either seizure 
reduction or seizure freedom. However, the limitations of the available interventions 
mean that for a number of patients, seizure freedom will not be a realistic aim.  
 
1.2.6 Intractable Epilepsy 
 
Although treatments for seizure activity have improved in both their effectiveness 
and tolerability, approximately 20-30% of individuals with a diagnosis of epilepsy 
will go on to have chronic or intractable seizures (Shorvon, 1991; Richens & 
Perucca, 1993; Chadwick, 1998). The likelihood of intractability is not universal, 
with those who experience partial seizures or seizures as a result of hippocampal 
sclerosis more likely to have ongoing seizures than those with generalised seizures 
(Semah, Picot, Adam, Broglin, Arzimanoglou, Bazin, Cavalcanti, & Baulac, 1998).  
 
Surgery is often presented as the only option left for these individuals (Cull & 
Goldstein, 1997), although increasingly VNS is offered as an alternative. However, it 
is apparent that a significant number of those who are referred for tertiary level 
treatment continue to experience ongoing seizures. Therefore, it is vital that there is 
an understanding of how these individuals react to both their diagnosis and the 
consequences of living with a chronic health condition. As Cull and Goldstein (1997) 
suggest, it may be that psychological treatments and processes will be vital in the 
ongoing management of these patients.   
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One of the fears within the field is that those with intractable seizures are at greater 
risk of developing psychopathology. Attarian et al. (2003) examined the relationship 
between depression and the intractability of seizures. They found that intractability 
of seizures did not appear to have a relationship with levels of depression, suggesting 
that those whose seizures remain active are at no greater risk of depression than those 
who have achieved better control.  
 
Although psychopathology does not appear to be increased in those with intractable 
epilepsy, quality of life for some does appear to be diminished for some. Baker, 
Smith, Dewey, Jacoby & Chadwick (1993) and Vickrey, Berg, Sperling, Shinnar, 
Langfitt, Bazil, Pacia, Kim & Spencer (2000) found that quality of life is 
significantly reduced in those with intractable epilepsy in comparison to those whose 
seizures were well controlled.  
 
The attitudes of patients with intractable epilepsy towards treatment have also been 
explored. Swarztrauber, Dewar & Engel Jr (2003), used focus groups to ascertain 
how these individuals felt about living with intractable epilepsy. Most of the 
participants described difficulties in accessing employment and in maintaining 
positive social relationships. There was also evidence that the group felt significant 
frustration at the process of trying many different medications to control their 
seizures. This is an interesting finding as it implies that the aims of the medical 
interventions may be at a tangent with that of the patients.  
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It would seem that the intractability of seizures has a multifaceted effect on the lives 
of people with seizures. Although there is little evidence that this group is at a greater 
risk of psychopathology, it would appear that levels of quality of life can be 
diminished. It is important to try to examine how this may come to pass and then to 
find methods that can in any way redress this apparent difference.  
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1.3 Quality of Life 
 
The advancement of medical science has resulted in an increasing ability for 
humanity to fight disease and prolong life. Whilst this has undoubtedly improved the 
overall wellbeing of the species in terms of increasing life expectancy and reducing 
preventable mortality, it has also produced a situation where the effects of disease 
management on longevity are promoted above the effects of the management 
strategy on the individual. This area is known as Quality of Life and suggests a focus 
beyond that of simple disease treatment with a more holistic approach to health 
outcomes.  
 
When discussing quality of life in epilepsy, it is important to highlight the general 
theory behind quality of life research, before moving onto more specific epilepsy 
related discussion.  
 
1.3.1 The History of Quality of Life in Healthcare 
 
As a concept, quality of life has absorbed a great deal of interest both from the 
clinical and philosophical communities (Jacoby, 2000). Formal examination of 
quality of life began with earnest in the 1940‘s with Karnovsky‘s creation of a formal 
measure, the Karnovsky Performance Index (Karnovsky, Abelmann & Craver, 
1948). Initially utilised to assess the overall efficacy of a new treatment for cancer, 
the measure was the first published instance of a medical appreciation of factors 
outside of disease progression and control.  
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Throughout the latter part of the 20
th
 Century, research continued aimed at firming 
up both the concept and the measurement of the concept. With an increased emphasis 
on quality of life from within the medical fraternity and from the commercial sector, 
in the form of pharmaceutical corporations, the field expanded exponentially. Jacoby 
(2000) highlights this in her review of the topic by stating that a Medline search 
using the term ―Quality of Life‖ for the years 1966-1970 yielded only 4 responses, 
whilst a similar search in 1995 produced 1000.  
 
The rise in popularity of the topic has not been without controversy. Critics have 
argued that quality of life is often an overused term, vague in both its definition and 
its measurement (Bishop & Hermann, 2000). Betts (2000) challenges whether or not 
quality of life can be accurately measured and how relevant are the findings from 
studies using quality of life outcomes in determining the development of future 
medical care. He argues that there is a tendency for quality of life measures and 
outcomes to be used in terms of short-term outcomes applied to pharmacological 
trials. Correctly, he questions the relevance of a short term approach to examining 
and investigating quality of life, which can lead to a meaningless analysis of factors 
that will not contribute to the well-being of the patient. Betts (2000) advocates 
quality of life study and measurement as a means to further the understanding of the 
patient journey, thereby giving the clinician a more balanced and useful view of how 
therapy should be delivered.  
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1.3.2 Quality of Life in Epilepsy 
 
There is a great deal of evidence to suggest that epilepsy can have a significant 
detrimental effect on the quality of life of those with the condition. From the physical 
effects of having the condition to the noted associations with psychosocial 
difficulties, the impact on the overall wellbeing of those with epilepsy can be both 
significant and detrimental.  
 
Kendrick (1997) introduces factors that may impact on the quality of life of those 
with epilepsy. She conceptualises these factors into three domains of medical, social 
and psychological factors. Within the medical factors she cites the occurrence of the 
seizures (frequency & severity, medication intrusion and side effects) and 
hospitalisation. The social factors include stigmatisation, family factors such as 
overprotection, employment difficulties and legal restrictions including driving. 
Under psychological factors, she lists direct cognitive difficulties, intellectual decline 
and psychiatric difficulties. 
 
Baker, Gagnon & McNulty (1998) investigated the relationship between quality of 
life and seizure type and frequency. Analysing data from the United Kingdom, 
France and Germany the authors found that both seizure type and seizure frequency 
were significant predictors of quality of life in the regression analysis with more 
severe seizures and more frequent seizures having a significantly poorer quality of 
life than those with infrequent or no seizures.  
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Leidy, Elixhauser, Vickrey, Means & William (1999) compared quality of life in 
people with a diagnosis of epilepsy and that of normal controls. Their study included 
an analysis of seizure frequency and its influence on quality of life within the 
epilepsy sample. The authors found that people with epilepsy who were seizure free 
had levels of quality of life similar to the age matched controls. Those who continued 
to experience seizures were found to have levels of quality of life significantly lower 
than both the seizure free group and the controls. Within the intractable epilepsy 
group, Leidy et al (1999) found that seizure frequency was a significant predictor of 
quality of life, with higher frequency negatively correlating with quality of life. 
Some weaknesses were apparent within the study. Patients who had a diagnosis of 
clinical depression were excluded on the grounds that their condition would have an 
impact on quality of life beyond that of the epilepsy alone. As stated previously, 
depression is a potentially co-morbid condition with epilepsy, and the exclusion of a 
potentially influential group of patients may have resulted in a bias within the sample 
towards those who were higher functioning. Also, the data for seizure frequency 
were categorised in the analysis into three 3 variables, rather than entered as raw 
scores. It could be that by using arbitrary cut-offs individuals were grouped 
inappropriately, resulting in possible bias.  
 
The results of Leidy et al. (1999) were supported by a further study by Birbeck, 
Hays, Cui & Vickery (2002) who investigated the quality of life of individuals with 
epilepsy in various stages of seizure status. They found that improvements in quality 
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of life were most significant in those who had achieved seizure freedom. However, 
the authors were unable to detect a statistically significant difference in quality of life 
in terms of seizure frequency in those who did not achieve seizure freedom. This 
suggests that although seizure freedom is an important goal in treatment, it may be 
that in those for whom this is not possible, seizure frequency is less of an issue than 
was previously thought. The design of this study did not take into account any factors 
beyond seizure frequency. The authors concluded that seizure freedom was an 
imperative for any improvements in quality of life. However, this inference was 
based on the outcomes from measures solely focussed on quality of life and seizure 
frequency and did not take into account psychosocial variables. This study also 
excluded individuals who had an increase in seizure frequency of over 50% and as a 
result 5% of individuals were excluded from the final analysis. The authors did not 
report the reason for this decision, and it is possible that this may have made the 
sample unrepresentative.  
 
Conceptually, the belief that good physical health equates to optimal quality of life is 
deep-rooted within the health professions. The assumption is that individuals with 
health problems are unable to achieve reasonable levels of quality of life (Albrecht & 
Devlieger, 1999). Albrecht & Devlieger examined the quality of life profile of 153 
people with a wide range of disabilities from HIV/AIDS to mental health problems. 
Using a qualitative approach, the authors reported that 54.3% of people with serious 
disabilities had good or excellent quality of life. They compared this to the 
population with no disabilities who report good or excellent quality of life in 80-85% 
of cases. The analysis of the data indicated that common factors identified with better 
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quality of life in the disability sample were higher levels of social support, resilience 
and acceptance. This study was of good quality in terms of the scope of conditions 
that were included and also in terms of the high number of interviews that were 
analysed.  
 
Gilliam & Kanner (2002) highlighted the importance of concentrating on factors 
beyond seizure frequency. They reviewed the data regarding the role of depression in 
the outcomes of quality of life for those with intractable epilepsy and concluded that 
much of the variance in the outcomes for those with epilepsy could be explained by 
disorders of mood, beyond any influence of seizure frequency.  
 
This was confirmed by a study by Tracy, Dechant, Sperling, Cho & Glosser (2007), 
which investigated the contribution of depression and anxiety and seizure related 
variables in the quality of life of those with epilepsy. They examined the variables 
using stepwise linear regression and found that levels of depression accounted for the 
highest amount of the variance in quality of life, with only a small amount explained 
by the seizure related variables. The authors suggest that in any treatment model for 
epilepsy, psychological variables should be addressed as these can directly improve 
the individual‘s quality of life.  
 
Gilliam, Kuzniecky, Meador, Martin, Sawrie, Viikinsalo, Morawetz & Faught 
(1999), analysed the outcomes from a group of 71 surgery patients and found that 
mood status provided the greatest account of the variance in the quality of life 
outcomes. Neither lower seizure frequency nor seizure freedom were associated with 
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improved outcomes. The results of this study indicate the difficulties in a treatment 
model that only examines the physical outcomes in epilepsy. 
 
Bishop & Allen (2003) conducted one of the few qualititative studies to examine 
epilepsy and quality of life. Using a postal survey, 46 participants completed an open 
ended questionnaire that asked them to rate their quality of life and then to list 
aspects that they felt were important in helping them arrive at this rating, both 
positive and negative. Using an open-coding technique, the authors identified ten 
domains within three functional domains of intrapersonal, interpersonal and 
extrapersonal. The domains identified are listed in Table 3.  
 
 
Intrapersonal Interpersonal Extrapersonal 





Self Concept Religion Spirituality Leisure Activities 
Mental Health   
Table 3: Domains identified from the participant’s responses (Adapted from 
Bishop & Allen, 2003) 
 
Further analyses were conducted to examine what issues were important contributors 
or detractors in quality to life to people with epilepsy. These items are listed, along 
with the number of participants who gave responses that were coded into each 
domain, in Table 4.  
 
 
















Religion/Spirituality 15 Stigma/Perceived Stigma 12 
Leisure Activities 13 Restrictions on Freedom 12 
Basic Needs Met 13 Seizures 10 
Positive Self Concept 9 Cognitive Limitations 8 
Employment 9 Seizure Worry 8 
Health 8 General Health 8 
Independence/Autonomy 7 Employment Restrictions 8 
Seizure Control 5 Medication Effects 7 
Helping Others 5 Health Care Problems 6 
  Social Isolation 6 
  Problematic Family 
Relationships 
5 
Table 4: Items identified as important contributors and detractors and the 
number of participants who reported them (Adapted from Bishop & Allen, 
2003) 
 
Participants in the study identified psychosocial factors as the primary factors that 
influence their quality of life, notably the influence of the family and the role played 
by psychological distress. Seizure control, health problems and the occurrence of 
seizures were less endorsed, but still relatively important. The results suggest that 
focus should be aimed at not only improving the clinical outcomes for people with 
epilepsy, but also in investing time in identifying those psychosocial factors that are 
important to the individual.  
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Johnson, Jones, Seidenberg & Hermann (2004) further examined the relationship of 
psychological variables in quality of life in epilepsy in comparison to seizure related 
variables. They found that the clinical variables (seizure frequency, seizure severity 
and duration of condition) did adversely affect quality of life in their sample. 
However when the psychological variables of anxiety and depression were included 
in the analysis, they became a more powerful predictor of the variance than the 
clinical variables. The authors concluded that any treatment of epilepsy must take 
into account the relative roles of psychological factors in order to provide the person 
with the best means to recovery.  
 
Loring, Meador & Lee (2004) investigated the role of depression in quality of life. 
115 patients with intractable epilepsy were identified and completed measures 
including the QOLIE-89, BDI-II and a measure of seizure worry. Regression 
analyses indicated that depression accounted for the greatest amount of variance 
within the sample (R2 = 0.45), with seizure worry providing the next highest amount 
(R2 = 0.42). Loring et al. (2004) reported that symptoms of depression and seizure 
worry are the two most important determinants of quality of life in intractable 
epilepsy.   
 
Jacoby & Baker (2008) explored the quality of life trajectory in people with 
intractable epilepsy. The trajectory of a condition is regarded as the course and 
likelihood of events occurring during the time scale of the illness. Using this model 
the authors examined the literature to identify the expected progression of quality of 
life. They argued that seizure frequency had little impact on levels of quality of life 
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and suggested that the severity of the seizures may be more important. It was also 
suggested that the quality of life of those with intractable epilepsy will likely rise and 
fall over the course of the condition. The likely cause of these changes would be the 
non-clinical aspects that are known to be associated with epilepsy, such as anxiety, 
depression and also resilience.  
 
Bishop, Berven, Hermann & Chan (2002) evaluated an exploratory model of quality 
of life among adults with intractable epilepsy. They conducted a literature review to 
identify the pertinent physical, social and psychological variables that may affect 
quality of life. They included; perceived social support; physical function; perceived 
general health; mental health (freedom from anxiety or depression); employment 
status; seizure frequency and perceived interference by the seizures in daily life. In 
their initial model (Figure 2) they predicted that seizure frequency and seizure 
interference would be the strongest predictors of quality of life. The model was 
tested using path analysis and the relationships discovered between the variables 
prompted a revision of the model. Seizure frequency accounted for only 0.16 of the 
negative variance on quality of life, although it did have an indirect influence 
through its relationship with social support. Seizure interference had no direct 
relationship with quality of life, but did have an indirect influence through general 
health. The main direct contributors to quality of life were social support, general 
health and mental health.  The study suffered from a low response rate (19%) 
meaning that the results may not be representative of the population with epilepsy. 
The measure used for quality of life was the Life Situation Survey (Chubon, 1995) 
and this scale is limited in that it focuses solely on situational factors of quality of 
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life. It may have been more appropriate to have used an epilepsy specific scale or a 
number of different scales.  
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Figure 2: Path Model of the interrelationships among seizure frequency (FREQ), physical function (PF), seizure interference 
(INTER), social support (PRQ), general health (GH), mental health (MH), employment (EMP) and quality of life (LSS). 





















Szaflarski, Meckler, Privitera, & Szaflarski (2006) conducted a regression analysis 
on data from a sample of 99 patients who had intractable epilepsy. The aim of the 
study was to examine the influence of the age of the patient, the age of onset of the 
seizures and the duration of the condition on their health related quality of life. Using 
the Quality of Life in Epilepsy-89 (Devinsky, Vickery, Perrine, Hermann, Meador, 
Hays, & Cramer, 1995), the authors found that current age was not a significant 
predictor of quality of life, but age at onset and duration of the condition were 
significant predictors. Seizure frequency also was not a significant predictor in their 
first regression model. However, they conducted further multiple regressions using 
measures of depression and adverse life events. When this was done, the inclusion of 
these variables accounted for all of the predictive relationship. Szaflarski et al. 
(2006) suggested that the focus of outcomes on the condition specific aspects of 
epilepsy, such as onset and seizure frequency, overlooks the influence psychosocial 
aspects and that of mood.  
 
The evidence from this study highlights an important factor that may account for 
some of the observed trends in the literature. Although results concerning seizure 
type, frequency, duration of disease and many other factors have been found to have 
an association with quality of life in epilepsy, their influence may be masking the 
less obvious influence of psychological or psychosocial factors. The inconsistency of 
the results of these studies could be seen as an indication that there may be other 
explanations. Most of the studies discussed have neglected to include psychological 
or psychosocial factors. By focusing on the possible disease specific explanations of 
the observed variance of quality of life in those with epilepsy, perhaps the true causal 
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factors have been missed. This is not to exclude disease specific explanations of the 
variance, but is suggested merely to highlight that their influence may not be 
exclusive.  
 
Suurmeijer, Reuvekamp & Aldenkamp (2001) examined the role of psychosocial 
factors in the quality of life of 210 outpatients with ongoing epilepsy. The aim of 
their study was to investigate the perceived differences in quality of life in epilepsy 
from a psychological perspective, in addition to the more traditional medical 
explanations of seizure frequency and perceived severity of seizures. In addition to 
measures of physical functioning, psychological distress was measured using the 
General Health Questionnaire (GHQ), self-esteem was measured using the 
Rosenberg Self-Esteem Scale (RSE). No specific measure of quality of life was used 
within the study. The scale that was used was the Visual Analogue Scale-Delighted-
Terrible, which allowed participants to rate their quality of life on a ten point scale. 
The results of the investigation explained 44% of the overall variance in quality of 
life in their sample. Splitting the variables into three domains (physical functioning, 
social status and psychological status), the hierarchical regression showed that 
psychological status and social status explained 29% of the accounted variance, with 





Figure 3: Variance explained by factors in study by Suurmeijer et al. 
(2001) 
 
The results of the study by Suurmeijer et al. (2001) require careful interpretation due 
to methodological limitations. A visual analogue scale was used to assess quality of 
life. No reference for the scale was provided, meaning it was not possible to assess 
the suitability of the measure in this population. It may have been more appropriate 
to have used a more standardized scale to allow for future comparison.  
 
The studies above have highlighted the limited impact of seizure frequency on 
quality of life in those whose seizures are intractable. They have also indicated that 
psychosocial variables may be important in the overall variance of quality of life. 































positively on quality of life. One are that has shown to have a significant impact on 





Ann Jacoby, along with many of the other researchers in the field, has conducted a 
great deal of research into how stigma may impact on the quality of life of those with 
epilepsy. Although it is not possible to provide a comprehensive review of the 
conception of stigma, it can be loosely defined as the process by which an individual 
or group is deemed to be deviating from the societal or cultural norm, either in their 
behaviour or in their attributes. Some chronic health conditions can be viewed as 
stigmatising (Jacoby, Snape & Baker, 2005). Whilst diseases that are viewed to be 
outwith the individual‘s control are regarded in a more positive respect by others i.e. 
cancer, conditions where control is assumed to be more internally based are 
associated with higher levels of stigma (e.g. mental illness). Epilepsy can be viewed 
as stigmatising disorder, due to the relative lack of knowledge within the general 
public as to its causes and their fear of seizures and the subsequent deviation from 
societal norms (Temkin, 1971; Jacoby et al., 2005).  
 
The process of becoming stigmatised for people with epilepsy appears to involve a 
process of two parts, both through the feelings associated with having a stigmatising 
disorder and with the actual process of being stigmatised (Jacoby et al., 2005).  
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That stigma impacts on quality of life in epilepsy is well documented. Jacoby, Baker, 
Steen, Potts & Chadwick (1996) investigated the link between stigma and quality of 
life and found a strong linear relationship (Jacoby et al., 1996). Further studies have 
also identified stigma as factor in quality of life in epilepsy (Hermann, Wyler, Anton. 
& Vanderzwagg, 1990; Baker, Brooks, Buck, & Jacoby, 2000). The notion of stigma 
has some relevance to the overall impact of psychosocial or psychological factors on 
quality of life. Stigma can be perceived as reducing an individual‘s acceptance of 
their condition and can be thought of as a moderating variable in their responses to 
epilepsy. Both of these factors are associated with the concept of resilience and may 
indicate that this concept may be implicated in the overall variance of quality of life.  
 
In summary, the finding that the quality of life of those with intractable epilepsy can 
be diminished appears robust in the literature. However, the mechanisms of influence 
are less clear. It may be that stigma has a significant role, or it could be that many 
different factors combine to impact on quality of life. The intuitive approach would 
suggest that seizure frequency is the main moderator of quality of life. This is 
possibly supported by the reported evidence that suggests that those who are seizure 
free can achieve levels of quality of life similar to those without a chronic health 
condition. The difficulty in this approach can be seen with those who are not seizure 
free and still maintain high levels of quality of life. How can seizure frequency 
moderate this effect? Clearly, the role of seizure frequency in the quality of life of 
those with intractable epilepsy is less important than has previously been believed. It 
may be possible that factors similar to those reported by Suurmeijer et al (2001) 
could provide a better account  
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1.4 Resilience  
 
The concept of resilience is a relatively under-researched within adult 
psychopathology. Recent advances have been made in the fields of chronic pain 
(Karoly & Ruehlman, 2006) trauma research (Davidson, Payne, Connor, Foa, 
Rothbaum, Hertzburg & Weisler, 2005) and sexual abuse (McClure, Chavez, Agars, 
Peacock, & Matosian, 2008) but the term still provokes some confusion within the 
health professions. The following chapter will present an outline of the history of 
resilience research, before examining some of the evidence from fields other than 
epilepsy. The section will end with an introduction to the mechanisms that may be at 
play if resilience is a factor in quality of life in epilepsy.  
 
1.4.1 Historical Perspective  
 
As a concept, resilience has been in the realms of academic research for many years. 
However, the difficulty in researching and defining such a wide-ranging concept has 
meant that only recently has the issue of resilience moved from the philosophical to 
the scientific.  
 
Initial investigations into the concept of resilience were conducted in the field of the 
child development, specifically examining children of adults with schizophrenia. 
Garmezy‘s (1970, 1974) studies in this area were some of the first empirical 
investigations of people who displayed the trait of ‗competence‘ in the face of 
extreme stressors (Luthar, Cicchetti & Becker, 2000). Out of this work, the focus of 
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the research regarding competence remained within the field of child development. 
There are many possible reasons for this, but the main issue appeared to be the 
traditional notion that the skills developed by children during the developmental 
phase, protected them from psychopathology in later life. It was felt that adults who 
presented with psychopathology had missed their opportunity to develop these skills, 
and therefore required treatment solely for their disorder, rather than examining the 
possibility that these competencies were amenable to lifelong change. This type of 
thinking regarding a fixed capacity for resilience typified what Richardson (2002) 
calls the first wave of resilience theory.  
 
Dyer and Tusaie (2004) reviewed the literature concerning resilience. They explain 
that the development of the construct is rooted in two main areas of research. Firstly, 
psychological coping in the face of adversity laid the groundwork for interest in what 
factors mediated positive responses to psychological or environmental stress. 
Secondly, the increased understanding as to the physiological responses to stress 
meant that the interplay between physical symptomatology and psychological 
difficulties contributed to the idea that a concept could relate to both psychological 
and physical factors. Arguably, the two areas had previously been regarded as 
mutually exclusive. Therefore, the concept of resilience provides an overarching 
addition to the literature that attempts to explain the interplay between the 
psychological and physical responses to stress and adversity. Richardson (2002) 
states that the notion that resilience is a dynamic process in response to the presence 
of stress or adversity marks the arrival of the second wave of resilience theory. 
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Dyer and Tusaie (2004) go on to examine some of the literature behind the factors 
associated with resilience. They highlight two main areas of influence, namely 
intrapersonal and environmental factors. They state that the intrapersonal factors can 
be conceptualised as providing a protective shield from adversity or stress, with the 
environmental factors impacting on the development and action of the intrapersonal. 
These factors are listed in Table 5. 
 





Positive Coping Strategies 
Social Attractiveness 
Strong Belief System 
Strong Sense of Self 
Hardiness 
Educational Attainment  
Self-Esteem 
Stress Reactivity 
Perceived Social Support 
Life Events 




Table 5: Factors associated with resilience (Adapted from Dyer & Tusaie, 2004) 
 
1.4.2 Resilience as a concept 
 
As research into resilience continued, the concept of resilience moved away from the 
original theories of it being a fixed, finite resource into a more dynamic 
conceptualisation. As the theoretical progression continued, resilience began to 
replace many different concepts of positive reactions in the face of negative events, 
subsuming the notion of competence, unconscious defence mechanisms, risk vs. 
protection, hardiness and many others. As the concept continued to be more widely 
recognised through the late 20th Century, the rise of the movement of positive 
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psychology within psychological research began to expand the concept of resilience 
as a viable area of research across the lifespan and conditions. This idea of resilience 
as a concept can be viewed as the third wave of resilience theory (Richardson, 2002).  
 
This third wave of resilience theory is typified by the understanding that an 
individual‘s resilience will wax and wane throughout the lifespan, depending on the 
outcomes of specific life events. This means that individuals and their systems can 
both foster and reduce levels of resilience (Richardson, 2002). Therefore, the 
conceptualisation is that although resilient qualities can be revealed by the presence 
of stress or adverse events, they are also a resource that reveals itself in everyday life 
and can be modified or damaged. This ‗metatheory‘ of resilience marks the generally 
accepted thinking behind the concept at the current time. Therefore resilience can be 
defined as the possible outcome and the process by which an individual reacts to 
disrupting life events, either through positive adaptation, life stagnation or life 
digression (Kaminsky, 2006).  
 
Bonanno (2005) discusses the importance of challenging the view that resilience is a 
relatively rare phenomenon. He states that resilience in the aftermath of trauma 
represents a distinct pathway in successful adaptation, separate from the pathways of 
recovery, chronicity or delayed reaction. The pathway to a resilient response involves 
a lower initial response to the stressor, followed by a continued return to normative 
functioning. Studies have shown that this pathway to resilience is the most common 
reaction to potentially traumatic experiences occurring in 35-55% of those who are 
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exposed (Bonanno, Moskowitz, Papa & Folkman, 2005; Bonanno, 2004; McFarlane 
& Yehuda, 1996) 
 
1.4.3 Resilience across conditions and populations 
 
As resilience has become more accepted as a definable and measurable concept, 
research into the application of the theory to areas across the medical, educational 
and commercial fields has expanded.  
 
Davidson, et al. (2005) examined the effect of medication and CBT on levels of 
resilience in those who were being treated for post-traumatic stress disorder (PTSD). 
Ninety-two patients with chronic PTSD completed measures of resilience (CD-RISC, 
Connor & Davidson, 2003), trauma and disability. The sample were randomized into 
4 groups
2
 and following completion of treatment, pre/post total CD-RISC scores 
were analysed for the whole sample. The overall effect size for the group was 0.72, 
with Tigabine providing the highest improvement (ES = 1.06). They also reported 
improvements in the CBT group, albeit with a smaller effect size (ES = 0.55). 
However, they did report that the limitations of their study, namely a lack of a 
control and a small n mean that it is difficult to generalise the results. Also, the group 
receiving CBT did so as a 5 week adjunct following 10 of weeks of medication 
treatment. As well as being unable to separate the effects of the drug and the CBT, 
the limited duration of the psychotherapeutic input may mean that the effect size is 
perhaps less than it could have been.   
 
                                               
2 The groups were; Tiagabine, Fluoxetine, Sertraline and Sertraline followed by CBT 
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Karoly & Ruehlman (2006) investigated the role of resilience in the field of chronic 
pain. They conducted a comparison of the psychological correlates associated with 
resilience in two groups of individuals with matched levels of pain severity. The 
results indicated that the resilient sample showed significantly higher levels of 
positive coping, lower use of medication or medical services, lower levels of 
catastrophising and more adaptive attitudes to both their pain and their beliefs 
regarding the future. The authors couched the results of their study in terms of the 
self-regulatory approach to chronic illness (Bandura, 2005), suggesting that 
resilience can be viewed as the outcome of an adaptive process of integration of new 
goals within the framework of their ongoing health difficulties. One area where the 
authors highlighted a limitation with the study was in their assumption that levels of 
resilience would remain stable across the timeline of dealing with chronic pain. 
Karoly & Ruehlman suggest that the use of a longitudinal design could account for 
this deficiency. The method of recruitment in this study could also be criticised. 
Participants were contacted via random telephone number generation and screened 
for the presence of chronic pain using a standardised pain scale. If they provided 
responses above a designated cut-off, they were invited to take part in the study. At 
no point were the individuals interviewed regarding the cause of their pain or how 
their pain arose. It is possible that the sample selected may have been over-inclusive 
and may not have been a true representation of those with chronic pain.  
 
Farber, Schwartz, Schaper, Moonen, & McDaniel (2000) examined the role of 
several factors within the concept of resilience (commitment, challenge and control) 
into the overall levels of psychological distress, quality of life and core self beliefs, 
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in a population of 200 patients with a diagnosis of HIV and AIDS. The results of the 
study indicated that the high levels of the resilience factors were associated with 
significantly lower levels of psychological distress, higher levels of quality of life 
and significantly more positive core beliefs. The conclusion made by the authors was 
that resilience has a strong influence on levels of psychiatric co-morbidity in people 
with HIV or AIDS.  
 
Some research has examined the promotion of resilience within the workplace using 
a group-based treatment (Millear, Liossis, Shocet, Biggs & Donald, 2007). The 
authors examined the effect of an 11-week intervention based on a program entitled 
―Promoting Adult Resilience‖ (PAR). Twenty individuals taken from a workforce 
sample were allocated to the treatment condition, with a group of 51 volunteers from 
a work place well being program constituting the control group. Although no direct 
measure of resilience was used, outcomes included measures of coping self-efficacy 
and optimism, anxiety, depression, stress, life satisfaction and psychological well-
being. Comparisons between the groups indicated that the PAR group improved 
significantly on measures of coping self-efficacy and optimism, depression and 
stress. The authors concluded that PAR program showed improvements on the 
factors associated with psychological resilience. Given that the sample was drawn 
from a non-clinical population, it is not possible to generalise the results to clinical 
cohorts. However, the results do suggest that treatment programs can be created that 








Although no studies exist that directly examine resilience and epilepsy, a number of 
investigations have been conducted into the influence of coping style, and how this 
can affect overall quality of life. Resilience is known to resemble the concept of 
coping, but the scale of the concept of resilience is much broader than that of coping 
(Karoly & Ruehlman, 2006). Both concepts share some commonality in terms of the 
self-awareness of an individual to make the best of their situation and these common 
factors would indicate that the literature on coping in epilepsy may inform as to the 
utility of applying the concept of resilience to the condition. Osterhuis (1999) 
examined the different types of coping in a population of adults with epilepsy and 
found that those who employed an active approach style of coping perceived their 
seizures as significantly less threatening. They were also less likely to have clinical 
symptoms of anxiety or depression. 
 
Krakow, Buhler & Haltenhof (1999) investigated the coping behaviour of patients 
with intractable epilepsy. They examined the responses of 40 patients on measures of 
coping, depression, locus of control and psychosocial adaptation. The results of their 
analysis indicated that individuals who engaged in problem-focused and active 
coping strategies had better outcomes in terms of depression and psychosocial 
adaptation. The study suffered from a number of limitations. The sample used in the 
study were drawn entirely from an inpatient epilepsy population. This means that 
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results cannot be generalised to those in primary or secondary care. The study also 
used multiple correlations and it may be that a significance level of 0.01 would have 
been more appropriate than their chosen value of 0.05. Given that these styles of 
coping seem to correlate with the concept of resilience, it is clear that there is some 
utility in examining resilience in those with epilepsy.  
 
1.4.4 Resilience and Quality of Life 
 
The research literature indicates that the concept of resilience appears to be a 
reasonably acceptable possibility in providing an account of the reported variance 
seen in quality of life of people with epilepsy. All of the factors associated with 
resilience listed in Table 5, match well with those that are detailed to impact on the 
quality of life of those with the condition (Giovagnoli, Meneses & da Silva, 2006). 
Therefore, identifying those with epilepsy who have high or low levels of resilience, 
it may be possible to explain the reported discrepancies found in those whose seizure 
frequency does not appear to impact on their quality of life.  
 
Lawford & Eiser (2001) examined the links between resilience and quality of life. 
They suggest that the concepts are similar in terms of their multi-dimensionality, 
variability, latency of the constructs and also in their component domains. They 
questioned whether the two constructs may be related, and if so, whether the 
relationship is one of mediation or has a more direct, causal effect. The argument put 
forward suggests that the concept of resilience should be included in any theoretical 
model of quality of life. The authors also highlighted the difficulties in examining 
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both concepts and the need for there to be a clear conceptual model allowing for an 
understanding of the relations between the factors that comprise the concept.  
 
Jacoby & Baker (2008) outline the impact of quality of life ―promoters‖ in epilepsy. 
They reported that the evidence suggests that factors associated with resilience, most 
notably optimism and positive affect greatly increase the likelihood of an individual 
having good quality of life. The authors suggest that these resilience factors will have 
a greater influence on the quality of life in those with intractable epilepsy.  
 
In terms of how resilience can impact on quality of life in epilepsy, it may be useful 
to conceptualise this using the following model. The quality of life for an individual 
is threatened by many aspects including medical, social and psychological. These 
factors are then balanced by the strengths of the individual, be they internal or 
external. Although the balance of the system will be determined by the relative 
weights of the strengths and threats, the overarching concept of resilience will 
mediate the outcome. This model is based on the one proposed by Bishop, Berven, 
Hermann and Chan, (2002). If resilience is included in this model, the positive and 
detrimental factors may each be directly influenced by the levels of resilience. In 
some cases, resilience will negate the effect of the detrimental factors, thereby 
increasing the likelihood of a positive or stable response. In other cases, resilience 
will promote the impact of the positive factors, reducing the impact of the other 
factors. The quality of life of the individual will therefore be protected from negative 
experiences through the role of an individual‘s levels of resilience.  
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If resilience affects quality of life in epilepsy in this manner, the ability to predict 
how well an individual will cope with the intractability of their condition will 
provide a valuable tool in assessing future needs. Knowledge of this relationship will 
also allow for a better understanding of why some people with intractable epilepsy 
maintain reasonable levels of quality of life in spite of the chronicity of the condition. 
Finally, a better understanding of the relationship between resilience and quality of 
life would allow researchers to investigate whether changes in levels of resilience 
can bring about changes in quality of life.  
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1.5 Aims and Hypotheses 
 
The aim of the study is to examine the role of resilience in the quality of life in those 
with intractable epilepsy. Levels of anxiety, depression and seizure frequency will 
also be investigated, as the literature indicates that these factors may also display a 
relationship with quality of life.  
 
 
1.5.1 Hypothesis 1 
 
Levels of psychological resilience will be significantly positively associated with 
quality of life in individuals with intractable epilepsy. 
 
1.5.2 Hypothesis 2 
 
Resilience will be a stronger predictor of quality of life in people with epilepsy than 
seizure frequency.  
 
1.5.3 Hypothesis 3 
 


























The study incorporated a within subjects design with all participants completing the 
experimental questionnaires measuring quality of life, anxiety, depression, resilience, 
seizure frequency, employment and marital status, geographic location and 
educational attainment. Resilience, seizure frequency, and levels of anxiety and 
depression were included in the multiple regression on quality of life.  
 
2.2 Ethical Issues and Approval 
 
During the design of the project, a number of steps were taken in order to address 
ethical concerns. The main tool for providing potential participants with reassurance 
and information was through the use of a general information sheet. When creating 
the sheet, care was taken to ensure that potential participants were aware that their 
ongoing care would not be affected by participation in the study. It was also 
explained to potential participants that anonymity would be ensured and that the 
investigators would have no access to patient files. It was explained that the data 
collected would only be accessed by the main researcher and would be stored on 
NHS property on a password protected computer. The potential risks of participation 
were also highlighted and the availability of further support if required was 
explained. Individuals were considered to have given implied consent if they 
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returned their questionnaires as informed consent would have compromised 
anonymity.  
 
Ethical approval for the study was sought from the Tayside Committee on Research  
Ethics (Study Reference: 08/s51401/11) and from the University of Edinburgh 
Clinical Psychology Course Organising Committee. A change was made to the 
procedure by the Tayside committee, through the inclusion of an emergency contact 
in case of the study causing distress to the participants. Both the lead researcher and 
his direct clinical supervisor were included as emergency contacts. Although contact 
through these means would compromise the anonymity of the participant, it was felt 






Individuals were offered an opportunity to enter the study if they were aged between 
16-65, with a confirmed diagnosis of epilepsy and the presence of at least one seizure 
in the past six months, despite the use of anti-convulsant medication. Participants 
were excluded from the study if they had a current diagnosis of intellectual 
impairment or were actively psychotic. 223 patients were identified who met the 




The participants completed three experimental questionnaires. These were: The 
Quality of Life in Epilepsy Inventory- 31 (Cramer, Perrine, Devinsky, Bryant-
Comstock, Meader, & Hermann, 1998), The Hospital Anxiety and Depression Scale 
(Zigmond & Snaith, 1983) and the Connor-Davidson Resilience Scale (Connor & 
Davidson, 2003). They also completed a general clinical and demographic 
information sheet. A pilot of the measures with five healthy controls indicated that 
the measures would take between 20-30 minutes to complete. The participants were 
also provided with an information sheet regarding the study, both in terms of the 
overall aims and explaining what would be done with the data collected. Measures 




2.4.1 The Quality of Life in Epilepsy Inventory-31  
 
This Quality of Life in Epilepsy Inventory-31 (QOLIE-31, Cramer, Perrine, 
Devinsky, Bryant-Comstock, Meader. & Hermann, 1998) is based on the Quality of 
Life in Epilepsy Inventory-89 (QOLIE-89, Devinski et al., 1995). The QOLIE-31 
was devised by examining the factor loading of those items that were rated as most 
commonly important to people with epilepsy. The scale consists of 31 items 
organised into seven subscales—Seizure Worry (5 items), Emotional Well-Being (5 
items), Energy/Fatigue (4 items), Social Functioning (5 items), Cognitive 
Functioning (6 items), Medication Effects (3 items), Overall Quality of Life (2 
items)—and an additional item assessing overall health status. The raw scores are 
rescaled from 0 to 100, with higher values reflecting better QOL. Scores on the 
QOLIE-31 can be converted into T-scores, with a mean of 50 and a standard 
deviation of 10. In the current study, the raw QOLIE-31 scores were used.  
 
Reliability and validity are well established (Steinbuchel, Heel & Bullinger, 2000). 
The scale is widely used both in research and clinical practice and is the most 
frequently used assessment of quality of life in people with epilepsy (Cramer et al., 
1998). Internal consistency has been reported as lying between 0.77 and 0.85, with 
test-retest reliability ranging from 0.64-0.85 (Cramer et al., 1998). Written 
permission for use of the QOLIE-31 was obtained from the author. The scale has 
been translated and normed into numerous languages including Portuguese (da Silva, 
Ciconelli, Alonso, Azevedo, Westphal-Guitti, Pascalicchio, Marques, Caoclo, 
79 
Cramer, Sakamoto & Yacubian, 2007) Italian (Beghi, Mauro, & Roncolato, 2005), 
German, Danish, Spanish, French & Swedish (MAPI, 1996).  
 
2.4.2 The Hospital Anxiety and Depression Scale 
 
The Hospital Anxiety and Depression Scale (HADS, Zigmond & Snaith, 1983) is a 
14-item self-report questionnaire, commonly used to screen for symptoms of anxiety 
and depression. The 14-items can be separated into two 7-item sub-scales for anxiety 
and depression. Respondents are required to read each of the items and to indicate 
how much they agree with the statement on a 4 choice, 3-point scale. This provides a 
maximum score of 21 for each sub-scale. Scores can be placed on 4 ranges; 0-7 
normal; 8-10 mild; 11-15 moderate; 16-21 severe (Snaith & Zigmond, 1994). The 
scale has been found to display good levels of concurrent validity, with a medium to 
large correlation with other measures of depression and anxiety, such as the BDI-II 
(0.62-0.73) and the STAI-S (0.64-0.81) among others (Bjelland, Dahl, Haug & 
Neckelmann, 2002).  
 
Sensitivity and specificity levels have been reported to be approximately 0.80 when 
the scales use a cut-off score for anxiety and depression of greater than or equal to 8. 
Internal consistency has also been investigated and appears to be robust, falling in 
the range of 0.68-0.93 (Bjelland, Dahl, Haug & Neckelmann, 2002). The scale is 
used extensively in clinical practice and has been administered in numerous research 
studies involving people with epilepsy (Baker, Smith, Dewey, Jacoby & Chadwick, 
1993; Jacoby, Baker, Steen, Potts & Chadwick, 1996). The HADS is also regarded as 
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a more accurate measure of mental health in people with epilepsy than other 
measures of depression and anxiety (BDI-II; BAI), due to its emphasis on the 
behavioural and emotional symptoms of mental health, rather than on the physical 




2.4.3 The Connor-Davidson Resilience Scale 
 
The Connor-Davidson Resilience Scale (CD-RISC) is a brief self-report measure of 
resilience, defined by the authors of the scale as embodying the personal qualities 
that allow an individual to thrive in the face of adversity. The development of the 
scale was an expansion of work by Kobassa (1979) on the concept of hardiness and 
from Rutter and Lyons‘ (Rutter, 1985; Lyons, 1991) research into strategy generation 
and stress coping.  
 
The CD-RISC contains 25 items, all of which carry a 5-point range of responses, as 
follows: not true at all (0), rarely true (1), sometimes true (2), often true (3), and true 
nearly all of the time (4). The scale is rated based on how the subject has felt over the 
past month. The total score ranges from 0–100, with higher scores reflecting greater 
resilience. The authors of the scale report that it shows good levels of internal 
consistency (Cronbach‘s  α = 0.89), good levels of test-retest reliability (r = 0.87) 
and good convergent validity (Connor & Davidson, 2003). The development of the 
scale was conducted on both a sample from the general population and in a variety of 
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clinical conditions. Ahern, Kiehl, Sole & Byers (2006) evaluated the CD-RISC in 
comparison with 5 other measures of resilience and concluded that the scale is valid 
and reliable for use in the adult population.  
 
The scale is widely used in the research community, with studies using it to examine 
resilience in post traumatic stress disorder (PTSD) with adults, children and in terms 
of psychological functioning in older adults (Lamond, Depp, Allison, Reichstadt, 
Moore, Golshan, Ganaits & Jestes, 2008; Davidson, Payne, Connor, Foa, Rothbaum, 
Hertzburg & Weisler, 2005). The scale has also been utilised with adult anxiety 
disorders and self-esteem (Benetti & Kambouropoulos, 2006; Campbell-Sills, Cohan 
& Stein, 2005, Pollack, Stein & Davidson, 2004), chronic pain, cancer (Karoly & 
Ruehlman, 2006; Aspinwall & MacNamara, 2005), HIV and many other health 
conditions.  
 
Normative scores have been established for a number of conditions including 
individuals with PTSD, Generalised Anxiety Disorder, an inpatient psychiatric 
population, general psychiatric outpatients, general primary care populations and the 
general population (Connor & Davidson, 2003).   
 
 
2.4.4 General Information Sheet 
 
The general information sheet was created by the lead investigator in order to capture 
information regarding the clinical and demographic variables of the cohort. 
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Information regarding gender, age, marital status, educational achievement, seizure 
frequency, and area of residence were included within the sheet. The information for 
seizure frequency was obtained by asking respondents to self-report the number of 
seizures they experienced in the previous six months.  
 
2.5 Site of Study 
 
The Neurology Department of Ninewells Hospital provides neurological services for 
Tayside and part of Fife (population about 500,000) with clinics in Ninewells 
Hospital, Perth Royal Infirmary and Arbroath Infirmary.   In Ninewells Hospital 
there is a 14 bed Neurological Unit with a full supporting staff in Physiotherapy, 
Occupational Therapy, Speech Therapy, Medical Social Work and Clinical 
Psychology. There is a full range of Clinical Neurophysiological and 
Neuroradiological services.  In addition to general new and review neurological 
clinics, specialist clinics are held for epilepsy, with outpatient review supported by a 
specialist nurse in epilepsy. Epilepsy clinics are held on a weekly basis and internal 
departmental statistics indicate that in a three-month period (January-March 2008), 
286 patients were seen for reviews of their condition. This projects to an average 
yearly capacity of 1144 patient contacts.  
 
NHS Scotland provides specialist Neurology services in 4 areas (Tayside, Lothian, 
Greater Glasgow and Grampian). Although the composition of these services is 
heterogeneous in terms of staffing and facilities, the population coverage and staffing 





Individuals were recruited to the study through contact with their outpatient 
consultant neurologist in the Neurology Department at Ninewells Hospital, Dundee. 
All patients referred to the service would have experienced at least 1 seizure 
confirmed by EEG or through self-report, and would have undergone assessment by 
the consultant neurologist.  
 
During their review appointment, potential participants were informed that they were 
invited to participate in a study examining quality of life in epilepsy. If the patient 
indicated a desire to participate, they were provided with an information pack 
detailing the background information of the study, contact details and the 
experimental measures. This pack was to be taken home for completion and the 
experimental measures returned to the main investigator by pre-paid envelope. 
Patients were informed that their responses would be entirely voluntary and would 
remain anonymous. They were also informed that should they feel that they wished 
to discuss the study, they would be able to contact the main researcher in the first 
instance, although this would break some of their anonymity.  
 
The consultant screened for eligible patients during their preparation for the review 
appointments, and all of those who met the required criteria would be invited to take 
part in the study by either the consultant or the specialist nurse in epilepsy. 
Information was recorded by each clinician regarding the age, gender and diagnosis 
84 
of each patient who was provided with a pack, in order to record the overall 
characteristics of the invited sample for comparison with those who actually agreed 
to participate.   
 
2.7 Data Analysis 
 
All analyses were conducted using the Statistical Package for Social Sciences, 
Version 12. Hypothesis 1 stated that resilience would display a significant positive 
correlation with quality of life. To test this association, a Spearman‘s correlation was 
conducted on the data for resilience and quality of life. Hypothesis 2 stated that 
resilience would account for a greater level of the variance in quality of life than 
seizure frequency. A stepwise regression was conducted on the data for quality of 
life, with resilience, anxiety, depression and seizure frequency as the independent 
variables. Hypothesis 3 stated that resilience will be significantly negatively 
associated with levels of anxiety and depression Spearman‘s correlations were 
conducted.  
 
The strength of the relationships between variables for the correlations was analysed 
in line with Cohen (1988), who suggested that a small relationship would fall in the 
range of r = .10 to 29. A medium effect would fall in the range r = .30 to.49 and a 
large association would be in the range of .50 to 1.0 (both positive and negative 




2.8 Statistical Power 
 
Statistical power was calculated using the package G*Power 3 (Faul, Erdfelder, 
Lang, & Buchner, 2007). For hypotheses 1 and 3, a sample of 85 was calculated as 
being acceptable for a parametric correlation to obtain a power of .8, with a medium 
effect size of .3 and an error probability of 0.05. As the correlations were non-
parametric, this number was multiplied by 1.1 to obtain a required sample size of 94 
(Clark-Carter, 1997). For hypothesis 2, the results of the power calculation indicated 
that for a power level of 0.8, with a medium effect size of 0.15, and an error 
probability of 0.05, the required number of participants would be 85. The calculation 























Chapter 3: Results 
 
3.1. Demographic Variables 
 
Before conducting statistical analyses, the data were investigated in terms of 
demographics. 223 individuals were invited to take part within the study.  Sixty 
individuals returned the questionnaires, giving a return rate of 26.9%. Of the 60 who 
participated in the study, 28 (46.7%) were female and 32 (53.3%) were male. The 
mean age of the participants was 37 (Standard Deviation = 11.2, range = 21-59). In 
order to evaluate whether the experimental group was representative of the available 
sample, data on age and gender was collected for all individuals who were invited to 
participate in the study. Table 1 demonstrates that age and gender for the 
experimental group was similar to that of the overall available sample. An unpaired 
samples t-test showed that the groups did not differ significantly in terms of age (t = 
0.062, p = 0.950). Chi-square analysis confirmed that the groups did not differ 










Table 1: Means and percentages for the experimental group and the whole 
sample  
 Whole Sample 
n = 233 
Experimental Group 
n = 60 
Age Mean  36.9 
SD  11.45 
Mean  37.0 
SD  11.17 
Gender 126 female (56.5%) 
97 male (43.5%) 
28 female (53%) 




Demographic data is outlined in Table 2. Of those who participated 56.7% were 
married, 33.3% single and 10% in a long-term relationship. Thirty percent of the 
participants had some secondary, 50% college education and 20% with a University 
education. Employment status was 46.7% employed full-time and 8% unemployed, 
whislt 36.7% were employed on a part-time basis. Geographically, the individuals 
who returned questionnaires were predominantly from the Dundee metropolitan area, 





















Table 2: Demographic data for the experimental group 
 
 
The means and standard deviations for the experimental group for measures of 
quality of life, seizure frequency, anxiety, depression and resilience are displayed in 




n = 32 (53%) 
n = 28 (47%) 






Marital Status Single 
Married 
Long-term partner 
n = 20 (33.3%) 
n = 34 (56.7%) 






n = 18 (30%) 
n = 30 (50%) 










n = 28 (46.7%) 
n = 22 (36.7%) 
n = 1   (1.7%) 
n = 2  (3.3%) 
n = 2  (3.3% 
n = 5  (8.3%) 
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Quality of Life 
 
61.42 1.53 
Table 3: Means and Standard Deviations for main experimental measures 
 
3.1.2 Exploration of the Data 
 
Prior to statistical analysis, the data were examined in terms of their distribution. The 
presence of skewness or kurtosis was examined for the variables of quality of life, 
depression, anxiety, seizure frequency and resilience. This was done by calculating 
the ratio of the possible skewness or kurtosis with its standard error. Depression and 
anxiety showed a positive skew. Resilience showed a significant level of kurtosis and 
visual examination of the data indicated a bi-modal distribution. Quality of life also 
displayed a slight bi-modal distribution. Seizure frequency was found to be normally 
distributed.  
 
Given the deviations from normality demonstrated by the variables anxiety, 
depression, resilience and quality of life and their non-interval nature, non-
parametric Spearman‘s correlations were used to test hypotheses 1 and 3.  
 
In order to test Hypothesis 2, a stepwise regression was required. In order to enter the 
data for resilience into the equation, the data was recoded into two categories based 
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around the median of the score for the scale. The dichotomised data were used solely 
in the regression analysis, with all subsequent analyses including resilience using the 
raw scores. Depression and anxiety also showed elements of a non-normal 
distribution, but the decision was made that they were to be included in the 
regression due to the robustness of the test to violations. The distributions of the 
variables are displayed in Appendix VII. 
 
 
3.2 Hypotheses Related Data Analysis 
 
3.2.1 Hypothesis 1 
 
Levels of psychological resilience will be significantly positively associated with 
quality of life in individuals with intractable epilepsy. 
 
A Spearman‘s correlation was conducted on the data for quality of life, measured by 
the Quality of Life in Epilepsy Scale-31 (QOLIE-31) and resilience, measured by the 
Connor-Davidson Resilience Scale (CD-RISC). A large significant positive 
relationship was found (r = 0.818, n = 60, p < 0.001) indicating that higher levels of 
resilience are associated with higher levels of quality of life. A scatterplot of the 
relationship between quality of life and resilience is displayed in Appendix V.  
 
3.2.2 Hypothesis 2 
  
Resilience will be a stronger predictor of quality of life in people with epilepsy than 
seizure frequency.  
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A stepwise regression was conducted with quality of life as the dependent variable 
and resilience, seizure frequency, anxiety and depression as the independent 
variables. Correlations indicated that seizure frequency did not show a significant 
relationship with quality of life. However, the decision was made to include seizure 
frequency in the analysis as previous studies have found it to be a factor in quality of 
life. As mentioned previously, data on resilience were recoded into two categories 
around the median, in order to satisfy parametric assumptions. No multicolinearity 
was found within the data.  
 
Stepwise regression identified two variables that accounted for approximately 79% 
of the variance in quality of life. Resilience accounted for 77% (R2 = .775) with 
depression accounting for 2% (R2 = 0.015). Neither anxiety nor seizure frequency 
were found to contribute to the model. Table 4 displays the standardised betas, t-






t statistic Significance 
Resilience 
 
.748 8.383 <0.001 
Depression 
 
-.180 -2.016 <0.05 
Anxiety -.158 -1.198 >0.05 
Seizure 
Frequency 
.188 1.434 >0.05 
Table 4: Betas, t statistics and significance levels for the stepwise regression on 








3.2.3 Hypothesis 3 
 
Resilience will be negatively associated with measures of anxiety and depression.  
 
Spearman‘s correlations were conducted between resilience (CD-RISC), anxiety and 
depression, as measured by the Hospital Anxiety and Depression Scale (HADS). The 
results indicated that resilience and anxiety showed a large significant inverse 
relationship (r = -.707, p < 0.001) and resilience and depression also showed a large 
significant inverse relationship (r = -.667, p < 0.001). Scatterplots of the relationships 




3.3 Exploratory Analyses 
 
Further examination of the data was conducted to investigate the effects of levels of 
anxiety and depression on quality of life. The data were also investigated in terms of 
the demographic variables and their relationship with quality of life. A final analysis 
was conducted to investigate whether the group differed on measures of resilience 
and quality of life dependent on the presence of significant symptoms of anxiety or 
depression.  
 
3.3.1 Anxiety, Depression and Quality of Life 
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Spearman‘s correlations were conducted between quality of life and both anxiety and 
depression. There was a large significant inverse relationship between anxiety and 
quality of life, (r = -.706, n = 60, p < 0.001). A similarly large significant inverse 
relationship was present between depression and quality of life, (r = -.711, n = 60 p < 
0.001).  
 
3.3.2 Marital Status and Quality of Life 
 
Marital status was recoded into two variables; relationship or no relationship. A 
Mann-Whitney test was conducted to determine whether there were any statistical 
differences between those who were in a relationship and those who were not. The 
results indicated that there was no significant differences between the groups (U = 
397.5, p = 0.975). 
 
3.3.3 Education Level and Quality of Life 
 
The relationship between education level and quality of life was examined by 
separating the group into three separate groups. These groups consisted of those who 
had only a secondary education, those who had a college education and those who 
had attended university. A Kruskal-Wallis test identified no statistically significant 
differences in quality of life across the three groups (KW = 5.598, p = 0.0609).  
 
3.3.4 Employment and Quality of Life 
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The majority of the sample were in some form of employment (n = 50). Therefore, it 
was not possible to compare the group in terms of those who were employed and 
those who were not. However, analysis was conducted to investigate if there was any 
difference in quality of life of those who were employed full-time and those who 
were employed part-time. A Mann-Whitney test was conducted and the results 
indicated that there was no significant difference in quality of life between those who 
were in part-time employment and those who were in full time employment (U = 
286, p = 0.674).  
 
 
3.3.4 The Impact of Anxiety on Resilience and Quality of Life 
 
The group was separated in terms of levels of anxiety into two groups; low anxiety or 
high anxiety. The Hospital Anxiety and Depression Scale currently has cut-off scores 
ranging from 0-7 for low symptoms, 8-10 for mild symptoms, 11-15 for moderate 
symptoms and >16 for severe symptoms.  Individuals who scored 10 or less were 
placed in the low anxiety group and individuals who scored 11 or greater were 
placed in the high anxiety group. The medians and range for the groups are displayed 
in Table 4.  
 
 
 Quality of Life Resilience 
High Anxiety 
(n 21) 











Table 5: Medians and ranges for the anxiety groups on measures of resilience 
and quality of life 
 
 
A Mann-Whitney test revealed that the groups differed significantly in terms of 
quality of life, with higher levels of quality of life being found in the low anxiety 
group (U = 83, p < 0.001). A further Mann-Whitney test indicated that the groups 
differed significantly in terms of resilience, with higher levels of resilience being 
found in the low anxiety group (U = 82, p < 0.001).  
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3.4 Summary of Results 
 
There was a large, positive significant association found between resilience and 
quality of life. Therefore higher levels of resilience were associated with higher 
levels of quality of life, supporting hypothesis 1.  
 
The results of the regression analysis indicated that resilience was a statistically 
significant predictor of quality of life. Seizure frequency did not provide a significant 
account of the variance. Therefore resilience was a stronger predictor of quality than 
seizure frequency in the current sample, which supports hypothesis 2.  
 
Resilience displayed large and statistically significant negative associations with both 
anxiety and depression. Therefore, higher levels of resilience were associated with 







CHAPTER 4: DISCUSSION 
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Chapter 4: Discussion 
 
4.1 Summary of the Research 
 
It has been suggested that factors beyond clinical symptoms may have an important 
role to play in the quality of life of those with epilepsy (Tracy et al., 2007; Johnson et 
al., 2004; Bishop et al., 2002). Researchers have estimated that psychosocial 
variables such as anxiety, depression, stigma, self-esteem and self-efficacy, may 
account for approximately 20-30% of the explained variance in the quality of life of 
people with epilepsy (Loring et al, 2004;Bishop et al., 2002; Suurmeijer et al., 2001). 
 
One psychosocial factor that has not received attention in epilepsy is psychological 
resilience. Resilience can be regarded as the process and outcome of positive reaction 
to stressful events (Kaminsky, 2006). The utility of investigating the role of 
resilience in the quality of life of those with epilepsy is informed from studies 
examining resilience in other chronic health conditions (Karoly & Ruehlman, 2006; 
Faber et al.  2000). The research in other conditions has suggested that psychological 
resilience can play an important protective role in allowing people to maintain good 
levels of functioning in spite of their difficulties.  
 
The primary aim of this study was to examine the role of psychological resilience in 
the quality of life of people with intractable epilepsy. Factors that may explain the 
variance in quality of life in those with epilepsy were investigated to determine 
whether resilience could explain a higher degree of the variance than seizure 
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frequency. The final aim of the study was to examine the relationship between 
resilience and anxiety and depression.  
 
People with epilepsy were identified through contact with their neurology 
department and asked to complete questionnaires examining resilience, quality of life 
and levels of anxiety and depression. 223 individuals were invited to take part in the 
study, of which 60 completed and returned the measures. It was hypothesised that 
psychological resilience would display a significant, positive relationship with levels 
of quality of life. It was also hypothesised that resilience would be a stronger 
predictor of quality of life in people with epilepsy than seizure frequency. Finally, it 
was hypothesised that resilience would display a significantly negative correlation 
with levels of anxiety and depression.  
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4.2 Discussion of the Research Findings 
 
4.2.1 Hypothesis 1 
 
Hypothesis 1 predicted that levels of psychological resilience will be significantly 
positively associated with quality of life in individuals with intractable epilepsy 
 
Psychological resilience is regarded as a possible protective factor in those with 
chronic health conditions (Karoly & Ruehlman, 2006). It is known that people with 
intractable epilepsy display lowered levels of quality of life compared to controls 
(Leidy et al., 1999). This lowered quality of life impacts negatively on both the 
individual‘s ability to cope with the condition and also on the overall impact of the 
condition in terms of health economics for society at large (Pugliatti et al., 2007). 
Resilience has been shown to be amenable to change and may possibly have an 
effect on levels of quality of life (Davidson et al., 2005).  
 
In the current study, the relationship between levels of resilience and levels of quality 
of life was investigated in those with intractable epilepsy. A significant, positive 
relationship was found between the two concepts, indicating that higher levels of 
resilience are associated with higher levels of quality of life. Therefore, it was found 
that the hypothesis that levels of psychological resilience will be significantly 
positively correlated with quality of life could be accepted. The results support 
previous work investigating factors associated with quality of life in epilepsy.  
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Bishop et al. (2002) found that factors such as mental health and social support are 
strong predictors of quality of life. The association found in the current study would 
potentially explain a degree of this variance given the possible protective role that 
resilience may have in protecting individuals from pathology.  
 
The finding that levels of psychological resilience display a large positive 
relationship with levels of quality of life, suggests that the two concepts show a 
strong association. Unfortunately, it is not possible to identify the nature of this 
relationship from the current study‘s findings as correlation does not imply causality 
(Clark-Carter, 1997). It could be that levels of resilience directly affect levels of 
quality of life or that levels of quality of life directly affect levels of resilience or that 
another factor influences both of the variables. A longitudinal study would allow for 
an investigation of the possible effect of resilience on quality of life. This could be 
done by measuring the relationship between the two concepts over a period of time 
to examine how the concepts change and whether an increase in one leads directly to 
increases in the other. If the nature of the relationship is causal (A causes B), then 
there is a possibility that by increasing levels of psychological resilience, levels of 
quality of life would also be increased.  
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4.2.2 Hypothesis 2 
 
Hypothesis 2 stated that resilience would be a stronger predictor of quality of life in 
people with intractable epilepsy than seizure frequency.  
 
Research has indicated that seizure frequency may have a significant negative 
relationship with levels of quality of life in those with intractable epilepsy (Birbeck 
et al., 2002; Leidy et al., 1999). However, these findings have not been reported 
consistently and it may be that psychosocial factors can provide a better account of 
the variance in quality of life (Bishop et al., 2002; Suurmeijer et al., 2001). It was 
hypothesised that levels of psychological resilience would be a stronger predictor of 
quality of life in people with epilepsy than seizure frequency. 
 
In the present study, resilience was found to explain a significant amount of the 
variance in the quality of life of those with intractable epilepsy. Seizure frequency 
was not found to explain a significant amount of the variance. This indicates that 
levels of resilience were a better predictor of levels of quality of life than seizure 
frequency in this sample.  
 
Seizure frequency did not correlate significantly with levels of quality of life and 
therefore no association between the variables was found. This does not replicate the 
findings of other studies into quality of life in epilepsy (Leidy et al., 1999). 
Additionally, the trend of the relationship between the seizure frequency and quality 
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of life was in a positive direction, which is the opposite from other studies examining 
the relationship between the two variables. Therefore it may be that the lack of a 
significant finding may invalidate the results of the analysis. The study suffered from 
a low n meaning that the chances of detecting a association was reduced and the 
possibility of making a type 2 error was increased. For this part of the study, it was 
calculated that for 2 variables entering the multiple regression analysis, an n of 98 
was calculated to produce a power .80 for a medium effect size (.15). As the study 
did not reach the required level of power (n = 60), it is not possible to state 
unequivocally whether a true finding has been achieved.  
 
The results of this section of the study indicate that resilience may provide a 
significantly better account of the variance in quality of life in those with intractable 
epilepsy, given the caveats mentioned previously. Although it would be premature to 
suggest that resilience is the primary predictor of quality of life, it would certainly 
warrant further investigation. This result also goes some way to explaining why 
seizure frequency has been a somewhat inconsistent predictor of quality of life. Other 
studies that have examined quality of life in terms of seizure frequency have found 
that when psychosocial factors are included in the analysis, the effects of seizure 
frequency are negated (Johnson et al., 2004).  
 
The overall effect of seizure frequency on quality of life was small and statistically 
not significant and in the opposite direction than would be expected based on 
previous research.  
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A further possibility is that there may be a publication bias in the literature, with 
studies that found an association between seizure frequency and quality of life more 
likely to be published than those that did not.  
 
4.2.3 Hypothesis 3 
 
Hypothesis 3 stated that resilience will be negatively associated with measures of 
anxiety and depression. 
 
The research into mood disorders in those with epilepsy indicates that those with the 
condition have a significantly elevated risk of developing anxiety or depression 
(Harden, 2002; Piazzini et al., 2001). Anxiety and depression are both linked to 
lower levels of quality of life (Cull & Goldstein, 1997). Therefore, in terms of 
examining the utility of the concept of resilience in quality of life in epilepsy, it was 
important to identify the relationship of resilience to these two factors. By examining 
this relationship, it will be possible to begin to model the possible mechanisms by 
which resilience impacts on quality of life. If there is a significant relationship 
between anxiety and depression and resilience, it may indicate that the effect of 
resilience on quality of life is an indirect one; resilience may mediate levels of 
anxiety and depression, which in turn, could impact on an individual‘s quality of life.  
 
The results of the study indicated that levels of resilience displayed a significant 
negative correlation with levels of anxiety and depression, with large effect sizes for 
both. These results suggest that higher levels of resilience are associated with lower 
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levels of anxiety and depression, and vice versa. As with hypothesis 1, it is not 
possible to assume a causal relationship between the variables as a result of only 
correlational analysis. Therefore it would be necessary to further investigate the 
relationship between the variables through the use of a longitudinal study design, 
where the movement within the variables across time could be further examined.  
 
4.3 Explanations to Account for the Research Findings 
 
4.3.1 Research Design 
 
The design of this study involved recruiting patients from a secondary care service. 
Although this provided the optimal means to access the greatest number of patients 
in the shortest time, it may have influenced the level of severity of the experimental 
sample. It may be that those managed in secondary care experience more severe 
epilepsy than those who are managed in primary care. Consequently, the results of 
the study are more generalisable to individuals with epilepsy attending secondary 
care than to those attending primary care. 
 
It also well documented that a significant number of people with epilepsy may be 
unaware of their condition (MacDonald et al, 2000) and that a number of individuals 
with the condition are not currently in the care of a medical professional (NICE, 
2004). It was not possible to gain access to this population in the current study due to 
time limitations and financial constraints. Future studies could attempt to include 
these individuals through advertisements in the press or in non-clinical sites.  
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In order to ensure that the sample used in the study were as representative as possible 
of individuals with epilepsy attending secondary care, data for age and gender of all 
of those who were eligible to be invited into the study was collected. This allowed 
the researcher to examine the representativeness of the experimental group. As seen 
in the Results chapter, the experimental sample and the invited sample did not differ 
in terms of their age and gender, suggesting that the experimental sample was 
representative of those with intractable epilepsy who are managed in secondary care. 
As seen in the Methodology chapter, the service at which participants were recruited 
is similar to other services in terms of patients seen and staffing levels (NHS 
Scotland, Information Services Division, 2005).  
 
A postal survey was used in order to recruit as many participants as possible. It may 
be the case that by not having direct contact with the participants, the possibility of 
interviewer bias was reduced. However, it is still possible that the participants may 
have made inferences regarding the type of person or organisation that have provided 









4.3.2 Response Rate  
 
Research using postal questionnaires is often fraught with difficulties in obtaining a 
reasonable number of returns to satisfy the demands of statistical power and also in 
gaining an adequate number of returns to ensure that the group as a whole is 
represented. For studies with low response rates there is always the possibility that 
the individuals who do return their data are in some way biased. For example, those 
who return the questionnaires may be highly motivated or have less severe symptoms 
of a condition and than those who do not return questionnaires (Oppenheim, 1992).  
 
In this study, the response rate was 26.9%, which can be considered low (Barker et 
al., 1994). Moran et al. (2004) used a postal survey in a study examining seizure 
frequency and quality of life in people with intractable epilepsy and reported a 
response rate of 48%. Cramer, Blum, Reed & Fanning (2003) also utilised a postal 
survey examining depression and quality of life and reported a response rate of 41%. 
Bishop et al. (2002) used a postal survey design examining the factors contributing to 
quality of life in epilepsy, and reported a response rate of 19%. Therefore, the 
response rate in the current study can be considered low in comparison with the 
majority of the literature.  
 
The possible reasons for a low response rate are multiple and some participants may 
have had difficulty in reading and completing the questionnaires due to problems 
with literacy. Although the questionnaires were designed to be uncomplicated, this 
factor cannot be ruled out, and it could be that the sample were biased by their 
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literacy skills. A further issue is that of the cognitive difficulties commonly 
experienced in this population, which may have impacted on the participant‘s ability 
to concentrate on completing the measures (Aldenkamp, 2006).  
 
Participants were also required to complete the questionnaires at home and 
participants consequently did not have someone involved with the study nearby to 
discuss the questionnaires with or have questions answered Contact details for the 
main researcher were provided and it was explained to the participants that should 
they have questions they could contact their consultant neurologist or the main 
researcher. However, by not providing a direct, face-to-face contact for clarification 
at the time of completion, it may have been that the sample were biased by their 
intellectual ability, with those who found the information easier to understand more 
likely to complete the measures. 
 
In order to try and increase the response rate in this study, various methods were 
utilised. Questionnaire packs included a pre-paid, pre-addressed envelope in order to 
increase the likelihood of a return. Also, clear statements regarding confidentiality 
were explicitly included in each section of the study. These statements included 
information regarding who would have access to the information and what would be 
done with the information following its collection. It was hoped that this would 
provide participants with a sense of reassurance regarding their data, thereby 
increasing the likelihood of the participant returning their data. Anonymity was also 
provided for the participants. This was done to not only protect the identity of the 
clients and satisfy data protection and ethical concerns, but also in the hope that it 
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would increase the likelihood of a return due to participants feeling more at ease with 
the protection of their identity. However, this also limited the ability to follow up 
non-responders. All of the methods mentioned above are recommended as methods 
to improve response rate in a postal survey (Oppenheim, 1992).  
 
A further possibility in explaining the response rate is that although all attempts were 
made to try and provide the participant with as much information as possible 
regarding the study, it may be that the overall length of the information sheets and 
experimental measures reduced the likelihood of a response. Oppenheim (1992) 
suggests that although the length of a questionnaire is a potentially confounding 
factor in completion rates, this tends to interact with the relevance of the information 
to the participant.  It is possible that the information provided to the participants may 
have resulted in a level of fatigue and therefore a lower overall response rate. 
However, the information provided in the questionnaires was deemed necessary by 
the Ethical Committee and it was hoped that the relative importance of the condition 
to the individual would counteract the effect of the length of the questionnaires. 
 
It was estimated that reading the information sheets and completing the 
questionnaires would take between 30-40 minutes, with 20-30 minutes of that time 
being questionnaire completion. Most studies do not provide data regarding the time 
taken to complete their questionnaires, although the choice of questionnaires was 
similar to that of other comparable studies (Harden, Maroof, Nikolov, Fowler, 
Sperling, Liporace, Pennell, Labar & Herzog, 2007).  
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It may have been that by using a postal survey design, valuable data were lost in 
terms of allowing participants to freely discuss the impact of epilepsy on their quality 
of life. A qualitative design would have provided the participants with the necessary 
freedom to inform the researcher of the areas that they feel impact greatest on an 
individual basis. The decision was made to use a quantitative design for two reasons. 
Firstly, the greater statistical power of the design allows for a better analysis of the 
relationships between the variables (Barker, et al., 1994). As this was the key aim of 
the study, a qualititative design would have been less appropriate as the smaller 
number of participants would have potentially clouded whether a real relationship 
was being observed. Secondly, the design was chosen to inform future theory which 
could be elucidated further by a secondary study using a qualitative approach. The 
detection of whether there is actually a relationship between the variables in the first 
instance, allows for a basis on which to inform a more in depth analysis through 
qualitative methods (Barker et al., 1994).   
 
The low response rate and potential biases amongst those who returned 
questionnaires would have to be considered when generalising the results from this 
study to other epilepsy populations. However the results from this study are likely to 
have some generalisability at least to other secondary care epilepsy services.  
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4.3.3 Statistical Power  
 
For Hypotheses 1 and 3, non-parametric correlations were used. The required sample 
size for the detection of a medium effect with power of .8 and an  <0.05 was 94. 
The current study had 60 participants. Therefore, the study was underpowered. This 
means that the results must be interpreted with caution and the hypotheses cannot be 
fully supported. However, given the size of the effects noted and the relative 
proximity of the sample to the required level of size, it would seem reasonable to 
infer that the noted relationships may have some validity.  
 
For the stepwise regression used to test hypothesis 2, an n of 85 was required to find 
an effect size of .15 at the .80 level of power, for an <0.05. As only 60 participants 
were recruited, the analysis was underpowered. As a consequence it may be that the 
inability to detect an effect for seizure frequency may have come about due to a lack 
of power, rather than as a result of a true interaction. The reasons for the lack of 
statistical power are threefold. Firstly, as outlined in the previous section, the 
response rate for the postal survey was lower than had been expected.   
 
Secondly, it may have been that the data collection window was not long enough to 
adequately allow for the return of a large enough sample of data. Although every 
effort was made to provide an adequate period of time to collect a large enough 
sample of data, a delay in receiving ethical permission to begin the study resulted in 
a 7-week delay in data collection.  
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A final point is that of the studies reliance on third parties to administer the surveys. 
The design of the study meant that the consultant neurologists within the epilepsy 
service would present participants with the measures. Although their input was 
essential to the study, valuable data collection time was missed as a result of poor 
communication between the main researcher and the consultants. However, given the 
proximity to the required level of power, the interpretation of the results appears 
relatively valid.  
 
For hypotheses 1 and 3, the use of non-parametric Spearman‘s correlations reduced 
the overall power of the findings. Given the non-normative distributions observed 
within the samples, it was not possible to satisfy the assumptions of parametric tests, 
even after conversion through algebraic means. Although the use of non-parametric 
tests is a valid means of hypothesis testing (Clark-Carter, 1997), their lack of power 
in comparison to parametric analyses means that their results are less likely to 
provide powerful result.  
 
The non-normative distribution of measures of depression and anxiety could 
potentially have limited the regression to two variables. It was not possible to convert 
the data using algebraic means. As resilience had already been converted into a 
dichotomised variable, neither depression nor anxiety could be dichotomised to enter 
the regression. The literature indicates that mental health may play an important role 
in the variance of quality of life in epilepsy, so their inclusion was warranted borth in 
terms of theory and statistical robustness. 
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4.3.4 Main Measures 
 
The reasoning behind the choice of the questionnaires chosen as the main measures 
is discussed in the Methodology chapter. A further examination of the main measures 
is required as it could be that the choice of the measures may have had a direct 
influence on the results of the study.  
  
The Quality of Life in Epilepsy Scale- 31 (QOLIE-31) 
 
The QOLIE-31 is a well-validated measure of quality of life in those with epilepsy 
(Steinbuchel et al., 2000). The decision to use the 31 item scale in this study was a 
compromise between the length of time taken to complete the scale and the depth of 
information obtained. The main difficulty in measuring quality of life is whether or 
not the selected scale has an acceptable level of construct validity (Steinbuchel et al., 
2000). It may have been more appropriate to have used the QOLIE-89 (Devinsky et 
al., 1995) in place of the shorter version, as it provides more items and gives a 
greater number of factors. However, the relative brevity of the QOLIE-31 in 
comparison to the QOLIE-89 outweighed the benefit of a more inclusive measure, as 
the concerns listed above regarding length of questionnaire detail. Also, the QOLIE-
31 is widely used in clinical research and is considered by the authors to provide an 
acceptable trade-off between content validity and ease of completion (Cramer et al., 
1998). The QOLIE-31 has also been found to correlate significantly with the QOLIE-
89 (Cramer et al., 1998). Consideration was also given to the possibility that the 
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length of the QOLIE-89 may have further reduced response rates. Therefore, it 
would appear that the choice of the scale was appropriate.  
 
It may have been appropriate to have included a battery of measures rather than a 
single scale in the measurement of quality of life. Given the difficulties in 
formalising the concept and attempting to measure quality of life as a single entity, 
inclusion of a measure such as the Liverpool Health Related Quality of Life Battery 
in Epilepsy (Baker, Jacoby, Smith, Dewey, Johnson & Chadwick, 1994) may have 
been warranted. Also, the inclusion of other more general measures of quality of life, 
such as the WHOQOL (Skevington, 1999) or the EuroQol (The EuroQol Group, 
1992), would have provided a more balanced view of quality of life. However, whilst 
it may be important to include multiple measures in terms of evaluating treatment 
effects, the practicality of conducting research means that a single measure may be 
acceptable (Steinbuchel et al., 2000) 
 
Connor-Davidson Resilience Scale (CD-RISC) 
 
The CD-RISC was chosen as the main measure of psychological resilience. This was 
done for a number of reasons. It is brief and simple to complete and, most notably, it 
displays strong psychometric qualities in terms of content validity and reliability 
(Connor & Davidson, 2003). Furthermore, the scale was chosen due to its ease of 
interpretation for the researcher.  
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In terms of its suitability for use with the epilepsy population, the authors of the scale 
do state that the CD-RISC does have utility in assessing coping in individuals who 
are experiencing reactions to highly stressful situations. Given that a diagnosis of 
epilepsy can be viewed as a threat to both the self and one‘s health, it was felt that 
the scale could be appropriate for this population and would provide a valid measure 
of resilience.  
 
As outlined in the Introduction, (1.4.2) resilience is not a unitary construct and 
comprises a multi-dimensional structure. Therefore, it may have been appropriate to 
have included multiple measures of the factors associated with the concept of 
resilience. These could have included measures of self-esteem and coping (Dyer & 
Tusaie, 2004). This would have allowed for a more in-depth analysis of the 
participants levels of resilience and may have produced a better understanding of the 
concept than would be found with the use of a single measure.  
 
The CD-RISC provides a ―snapshot‖ of an individual‘s levels of resilience. As 
mentioned in section 1.4.2, resilience can be viewed as a dynamic concept that will 
fluctuate over the lifespan (Richardson, 2002). It is possible that levels of resilience 
were not representative of the true situation for some of the participants, and may 
have been affected by current situational demands (such as martial stress or financial 
pressures). It may have been useful to have sampled levels of resilience over a 
number of time frames in order to counteract the effects of temporary stressors. 
Unfortunately the limitations of the timeframe of the study meant that this was not 
possible. In spite of the limitations listed above, the decision to use the CD-RISC 
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was made as the time taken to complete the scale is short, and it displays a high level 
of validity and reliability.  
 
 
Hospital Anxiety and Depression Scale (HADS) 
 
The HADS was chosen as the main measure of anxiety and depression for a number 
of reasons. As mentioned in the Methodology chapter, the scale has been widely used 
in populations with epilepsy and has acceptable validity and reliability. Also, the 
scale is brief and is relatively simple to score and interpret.  
 
Other scales that could have been utilised were both the Beck Depression Inventory 
II (BDI-II, Beck et al., 1996) and the Beck Anxiety Inventory (BAI, Beck & Steer, 
1990). Both scales have good psychometric properties and have been well used in 
clinical populations. However, some of the items included in the BDI-II may overlap 
with the physical symptoms of epilepsy and thereby produce a false representation of 
the true levels of depression Therefore, the BDI-II was discounted.  
 
A further issue may be that the use of a single measure for anxiety and depression, 
without the inclusion of a clinician rated scale may not have measured the true level 
of anxiety and depression within the sample. However, both the anxiety and 
depression scales of the HADS have shown good levels of construct validity in 
comparison to clinician-administered scales 0.86, (Bjelland et al., 2002). The 
inclusion of a clinician rated scale would have required the main researcher to 
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interview each participant individually, thereby reducing the likelihood of achieving 
a sample size large enough to have reached statistical power. Also, to have 
incorporated this design aspect would have required that participant anonymity be 





General concerns exist regarding the use of self-report measures in research. The 
tendency for individuals to engage in behaviours such as acquiescence and providing 
socially desirable responses is well documented (Barker et al., 1994). Although 
efforts were made to ensure that the scales used in this study took these tendencies 
into account, it is not possible to guarantee that our sample was not biased in terms of 
these factors. 
 
4.3.5 Seizure Type and Severity 
 
Previous research has investigated the influence of seizure type and severity on 
quality of life (Baker et al., 1998). It may be that these variables could provide an 
explanation of a degree of the variance in quality of life. Unfortunately, it was not 
possible to collect this data in the current study due to the difficulties in satisfying 
both ethical issues and the limited capacity of the study. To do this would have 
required careful examination of patient records, thereby negating patient anonymity. 
Although it may have been possible to collect this information within the general 
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information forms that were sent to patients, the lead clinician of the Neurology 
service recommended against this due to concerns regarding the patient‘s knowledge 
of their conditions. Whilst this was agreed at the time, it may be that questions 
regarding patient diagnosis and self-perceived seizure severity should have been 
collected.  
 
In summary, the observed experimental effects can be accounted for by a number of 
factors including the design of the study, the characteristics of the sample, the 
measures chosen and the analyses conducted. The current study has attempted to 
control for these confounds in order to provide an accurate account of the 
hypothesised phenomena. 
 
4.3.6 Seizure Frequency 
 
Data for seizure frequency were collected via self-report in the general information 
sheet. Reliance on a self-report was required due to the protection of anonymity 
inherent in the study design. It could be argued that the use of this method may have 
led to an inaccurate estimate of the actual occurrence of seizures and formal 
monitoring could have provided a more accurate estimate. Leidy et al. (1999) suggest 
that although this type of method would possibly be more accurate, most studies in 
epilepsy rely on self-report of seizure count.  
 
4.4 Future Research and Implications 
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The current study has examined the role of psychological resilience in the quality of 
life of those with intractable epilepsy. Given the research findings there are a number 
of possible areas for future expansion and examination that move on from the present 
question. 
 
4.4.1 Treatment in Intractable Epilepsy 
 
Current treatment models in those who continue to experience seizures are based 
firmly in medical attempts to gain freedom from seizures (NICE, 2004). Although 
this aim should remain at the heart of any treatment for the condition, it may be that 
by introducing further adjuncts to treatment, outcomes may improve, not only in 
terms of the clinical sequelae of the condition, but also in the more psychological 
factors. There is little evidence that a reduction in the frequency of seizures greatly 
improves quality of life (Pulsipher, Seidenberg, Jones & Hermann, 2006). Indeed 
much of the research has emphasised the importance of factors such as anxiety and 
depression in the quality of life of those with epilepsy (Szaflarski & Szaflarski, 2004; 
Cramer et al., 2003). In addition, both anxiety and depression are possibly more 
amenable to change than seizure frequency in those with intractable epilepsy.  
 
Some research has examined the promotion of resilience within the workplace using 
a group-based treatment (Millear et al., 2007). As this study was conducted within a 
workplace population, the merits of this type of approach are unknown within a 
clinical sample. Therefore, it may be that trials of this type of group-based therapy 
may be warranted within the field of epilepsy. This would allow for a more causal 
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analysis of how treatment aimed at fostering levels of resilience affects levels of 
quality of life in epilepsy.  
 
Improvements in resilience have been noted following intervention using a 
mindfulness based cognitive behavioural therapy approach. Hughes, Jordan & 
Schiraldi (2007) examined the effects of teaching resilience skills to a group of 
healthy young adults. Significant improvements were noted on measures of 
resilience, depression and anxiety. The authors concluded that resilience could be 
improved through the use of direct interventions using mindfulness-based 
techniques. This is further supported by Reibel, Gresson, Brainard & Rosenzweig 
(2001) who suggest that mindfulness promotes a significant level of cognitive 
appraisal, which in turn leads to improvements in psychological resilience.  
 
There is some evidence that the use of acceptance-based interventions can improve 
resilience. Kratz, Davis & Zatura (2007) investigated the impact of levels pain 
acceptance in a population with fibromyalgia. They found that levels of acceptance 
were positively associated with levels of positive affect. The authors indicate that this 
increased acceptance could be directly linked to a greater level of resilience against 
negative emotional states.  
 
 
Acceptance and Commitment Therapy (ACT) appears to be one type of treatment 
that may fit into a resilience model of quality of life in epilepsy. Hayes et al. (1999) 
define ACT as a contextually based of therapy designed to assist individuals in 
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modifying their behaviour from styles that encourage experiential avoidance of 
internal states, to ones that allow the client to experience these states without making 
judgments and decisions on the content of these thoughts or feelings. Some evidence 
regarding the development of ACT based treatments in epilepsy is beginning to 
emerge and the results appear to be promising (Lundgren et al., 2006). This area 
would appear to be one warranting further attention, and it may be that a group-based 
approach using ACT principles may directly affect the quality of life of those with 
epilepsy by increasing levels of psychological resilience.  
 
Another area where resilience and ACT may be incorporated into current treatments 
for epilepsy is by assisting patients in preparing them for the difficult time period 
following diagnosis of intractability. It is known that patients who receive a 
diagnosis of a chronic condition can foster feelings of resentment, anger and hostility 
both towards clinicians and the condition itself (Parker, Dumat & Booker, 1994). 
This can make it difficult for the patient to move on from the diagnosis towards a 
state of adaptation to the condition. Increasing an individual‘s level of resilience at 
this point could result in better adaptation.   
 
There is some evidence that by screening for resilience at the early stages of 
receiving a diagnosis of a chronic health condition, potential psychopathology can be 
identified and addressed. Connor & Davidson (2003) suggest that their scale may 
provide a useful tool in early identification of those who are exposed to highly 
stressful life events and may not have the coping skills or internal attributes to 
maintain normative functioning. The diagnosis of epilepsy and the subsequent 
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sequelae of the condition can be intensely stressful and de-stabilising (Baker, 1997). 
Therefore, research into how best to identify those who are most at risk of 
subsequent psychopathology would allow for a proactive approach for service 
planners and better follow up for the patient. However, the use of a screening 
questionnaire would need to be informed by additional factors such as clinical 
opinion, as it may be that there is a natural lowering in resilience levels following a 
diagnosis, and that these would recover in time. It could be that intervention at this 
stage could actually interfere with the natural recovery, as has been noted in the field 
of trauma research (Bisson, McFarlane & Rose, 2000).  
 
The links between resilience, anxiety and depression merit further investigation. The 
significant correlations found between these variables suggests that there may be 
interplay between the three variables. Depression and anxiety are more common in 
those with epilepsy (Gaitatzis et al., 2004) than those in the general population. 
Traditional therapeutic techniques have focussed on using cognitive-behavioural 
techniques to bring about symptom relief through behaviour change and challenging 
negative thinking styles (NICE, 2004). By investigating the effects of treatment 
aimed at treating anxiety and depression on levels of resilience, it would be possible 
better understand the relationship. A further question would be whether treatment 
aimed at fostering resilience could bring about improvements in anxiety and 
depression. 
Future research should also be aimed at examining further psychosocial factors and 
their influence on quality of life in intractable epilepsy. Given the low number of 
participants that were recruited in the current study, it was not possible to increase 
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the variables in the analyses, without reducing the power of the results. Variables 
such as adverse life events, depression, stigma, self-efficacy (Szaflarski, et al. 2006; 
Jacoby et al., 2005; Suurmeijer et al., 2002) have shown an effect on quality of life. 
As the research continues to identify the importance of psychosocial variables, 
further work should examine the mechanisms of the effects of each variable. This 
would allow for a model of quality of life to be constructed where the interplay 
between those factors that have a direct influence and those with an indirect 
influence could be better understood. This type of study would require a significant, 
multi-site design and lay beyond the scope or capacity of the current study.   
 
4.4.2 Clinician Knowledge of Quality of Life and Resilience in Epilepsy  
 
As the emphasis on outcomes beyond clinical factors has increased, clinicians are 
required to care for their patients in a more holistic fashion (Jacoby, 2000). Given 
that epilepsy has a number of negative psychosocial correlates, quality of life will be 
an area where clinicians may need to devote a degree of attention (Betts, 2000). 
Whilst most clinicians working in the field of epilepsy will be aware of the need to 
focus on quality of life, they may be less aware of what can done to improve the 
situation for their patients. As they may not be aware of interventions or advice that 
could be offered to their patients to help improve their condition, some clinicians 
may increase their focus on the areas where they feel that they have more of an 
influence, namely medical outcomes. It would be of interest to examine clinician‘s 
knowledge of what can be done to assist their patients in terms of quality of life. If a 
lack of knowledge is discovered, it could be that providing information regarding the 
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possible ways in which resilience could positively impact on quality of life could fill 
the knowledge gap.  
 
4.4.3 Clinical Issues in the Management of Epilepsy  
 
The NICE guidelines (2004) on the treatment and management of the epilepsies 
recommend the most efficacious treatments for the condition and offer advice to 
clinicians in terms of what information can and should be given to patients. The tone 
of the guidance is increasingly focussed on psychosocial aspects associated with 
quality of life. Of interest, were the recommendations that individuals with epilepsy 
should be informed of the increased likelihood of developing anxiety or depression. 
However, in the National Health Service, access to psychological therapies is limited 
and not all patients with epilepsy at risk of developing anxiety or depression will be 
able to access therapy in a timely fashion. It may be that little can be done to assist 
patients in dealing with the possible development of psychopathology other than 
referral on to a specialist adult mental health service or clinical health psychology 
service. However, if further investigation improves the explanation of the 
relationship between resilience and anxiety and depression in epilepsy, it may be that 
consultant neurologists and clinical nurse specialists would be able to provide 
information to the patient regarding behaviours or techniques that they could be 
using to foster their levels of resilience. This would provide a practical solution to the 
difficulties faced by an oversubscribed service under increasing pressure from 
governmental targets.  
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4.5 Summary and Conclusions 
 
This study examined the relationship between resilience and quality of life in 
individuals with intractable epilepsy. The hypotheses being tested were whether 
resilience and quality of life displayed a significant association, whether resilience 
could account for a greater amount of the variance in quality of life than seizure 
frequency and whether resilience demonstrated a significant relationship with 
measures of anxiety and depression. The results of the study upheld all of these 
hypotheses.  
 
The results of the research would suggest that there is a need for further investigation 
of the factors involved in levels of quality of life in patients with intractable seizures.  
As epilepsy is a heterogeneous condition requiring many different types of treatment, 
it would intuitively make sense to find ways in which the multiple outcomes of 
seizure frequency, seizure severity, seizure intrusion and quality of life can be 
improved. If resilience can assist either in improving quality of life or levels of 
anxiety and depression, then it may be a useful addition to the options available to 
services. 
  
Currently, the evidence base for therapies aimed at fostering resilience is in its 
infancy in the United Kingdom. Current guidance for the implementation of 
therapies requires that there should be a significant evidence base before treatments 
can be recommended as a frontline intervention. Therefore, considerable literature on 
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both efficacy and effectiveness of resilience-based therapies will be required before 
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TAYSIDE PARTICIPANT INFORMATION SHEET 
 
Quality of Life in Epilepsy in Adults: The role of psychological resilience 
 
My name is ********* and I am completing my final year of clinical psychology postgraduate 
training at the University of Edinburgh. I am required to undertake a project as part of my 
course and invite you to take part in the following study. However, before you decide to do 
so, I need to be sure that you firstly understand why I am doing it, and secondly, what it 
would involve if you agreed. I am therefore providing you with the following information. 
Please read it carefully and be sure to contact your consultant neurologist with any questions 
you may have.  
 
Background to the project 
This project is a joint project between the University of Edinburgh and NHS Tayside. We are 
looking at some of the factors that may be important in living with epilepsy. In particular, I 
am interested in which factors can account for better quality of life in those with the 
condition.  
 
What does the study entail? 
The study will involve you completing 3 questionnaires and filling out a basic information 
sheet regarding your condition and some historical details. There would be no need to meet 
directly with myself, as I will provide all the material by mail for return by pre-paid 
envelopes. The questionnaires are multiple choice and should take no more than 25-35 
minutes to complete. You will not need to provide your name on the questionnaire. Once you 
have sent off the questionnaires, you have completed the study. You will not be contacted in 
the future.  
 
 
Do I have to take part? 
It is up to you whether or not you take part. Only once you have read the information sheet 
and if you consent to participating, you need to complete the questionnaires and send them 
to me in the Stamped Addressed Envelopes. Taking the pack from the appointment does not 
mean that you have to take part. You are free to withdraw at any time and without giving a 
reason. A decision to withdraw at anytime, or a decision to take part, will not affect the 
standard of care you receive. This study is entirely separate from any contact you may be 
having with the NHS.  
 
What are the discomforts or risks? 
Some questions in the questionnaires may identify areas of difficulties or feelings that you 
had not fully considered before. If this happens and you are having difficulty coping with 
them, please let your neurologist know or feel free to contact your GP.  
 
 
What will happen to the information you collect about me? 
If you are willing to take part in the study, all the information about you and the responses 
that you give on questionnaires will be confidential with no names being asked of you. No 
personal information will be used in the write up of the study. The responses you give to the 
questionnaires will be collated with other participants’ responses to assess the factors that 
influence quality of life in epilepsy. All data will be stored on a password-protected computer 
with no personal identifiable information. Access to the questionnaires will only be granted 
to the principle researcher. 
 
What are your rights? 
Participation in the study is entirely voluntary and you are free to refuse to take part or to 
withdraw from the study at any point without having to provide a reason. Your decision 
whether or not to participate in the study will have no influence on any current or future 
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psychological or medical care you receive. It will also have no influence on your relationship 
with any healthcare staff you are involved with. 
 
The Tayside Committee on Medical Research and Ethics, which has responsibility for 
scrutinising all proposals for medical research on humans in Tayside, has examined the 
proposal and has raised no objections from the point of view of medical ethics. The 
committee will also receive regular reports from NHS Tayside Monitors who will examine the 
records of research while it is in progress. 
 
If you are willing to take part in this study please the questionnaires and information sheet 
and return them in the Stamped Addressed Envelope.  
 
 
What happens if I am injured or have a complaint as a result of taking part in this study?  
  
If you believe that you have been harmed in any way by taking part in this study you would 
have the right to pursue a complaint and any resulting compensation through the University 
of Edinburgh who are acting as the research sponsor. Details about this would be available 
through the research team. Also, as a patient of the NHS, you would have the right to pursue 
a complaint through the usual NHS process. To do so, you could submit a written complaint 
to the patient liaison manager, Complaints Office, Ninewells Hospital (Freephone 0800 027 
5507). Note that the NHS has no legal liability for non-negligent harm. However, if you are 
harmed and this is due to someone’s negligence, you may have grounds for a legal action 
against NHS Tayside, but you may have to pay your legal costs.  
 
 
Can I talk to someone regarding this study?  
 
If you would like more information regarding the study, you can get in touch with your 
consultant neurologist at Ninewells. You can also contact the main researcher, at the number 
listed above.  
 
 
What happens if I feel upset or worried after I have completed the 
questionnaires?  
 
Although there has been no indication that completing the questionnaires could cause any 
problems, if you have any difficulties, you should contact the main researcher, **********, 
who would be available to arrange further advice and support. If you do wish to contact Mr 
*******, please be aware that this would result in a loss of anonymity.  
  
This study is sponsored by the University of Edinburgh who have taken out insurance cover 
for this purpose.  Therefore, you may receive compensation in the event you are harmed by 
something unforeseen, i.e., when there is no negligence on the part of those conducting the 
study.  This will depend upon review of the circumstances that led to harm or injury and the 
likelihood it was linked to your participation in the study.  Such complaints should take this 
up initially with the lead investigator who is in charge of the study locally.  
 
Thank you for taking the time to read and consider the above information. If 
you are willing to take part in the study, please take time to carefully read and 













General Information Sheet 
 
 
Please fill in the following as accurately as you can. This information is used to look at general factors 





Gender (circle one):   Male Female 
 
 
Marital Status (circle one):  Single   Married   Long-term partner 
 
 




Employment Status (please circle the main category if you belong to more than one) 
 
Full time employed  Part-time employed   Self-employed 
 
Student   Homemaker  Without employment 
 
Voluntary worker   Other (please state):  
 
 
Please enter the first 4 digits of your postcode (i.e. DD2 1):  
 
 
When did you last have a seizure (please circle one)? 
 

























The QOLIE-31 is a survey of health related quality of life for adults with epilepsy. This questionnaire 
should only be completed by the person who has epilepsy (not a relative or friend) because no one else 
knows how you feel.  
 
 
There are 31 questions regarding your health and daily activities. Answer every question by circling 
the appropriate number  (1, 2, 3….). If you are unsure about how to answer a question, please give the 
best answer you can.  
 
1. Overall, how would you rate your quality of life?  
 











These questions are about how you FEEL and how things have been for you during the past four weeks. For each question, 
please indicate the answer that comes closet to the way you have been feeling.  
 
How much of the time during the past four weeks….. 
 
(circle one number on each line) 
 




A good bit 
of the time 
Some of the 
time 
A little of 
the time 
None of the 
time 
2. Did you feel full of pep? 
 
1 2 3 4 5 6 
3. Have you been a very nervous 
person? 
1 2 3 4 5 6 
4. Have you felt so down in the 
dumps that nothing could 
cheer you up? 
1 2 3 4 5 6 
5. Have you felt calm and 
peaceful? 
1 2 3 4 5 6 
6. Did you have a lot of energy? 
 
1 2 3 4 5 6 
7. Have you felt downhearted and 
blue? 
1 2 3 4 5 6 
8. Did you feel worn out? 
 
1 2 3 4 5 6 
9. Have you been a happy 
person? 
1 2 3 4 5 6 
10. Did you feel tired? 
 
1 2 3 4 5 6 
11. Have you worried about 
having another seizure? 
1 2 3 4 5 6 
12. Did you have difficulty 
reasoning and solving 
problems (such as making 
plans, making decisions, 
learning new things)? 
1 2 3 4 5 6 
13. Has your health limited your 
social activities (such as 
visiting with friends or close 
relatives)? 
1 2 3 4 5 6 
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14. How has the QUALITY OF YOUR LIFE been during the past 4 weeks (that is, how have things been 
going for you)?  
 
 
Very well: could  Pretty Good Good & Bad parts Pretty Bad  Very Bad: could 
hardly be better    about equal   hardly be worse 
 
 






         
 
15. The following question is about memory. In the past 4 weeks have you had any trouble with memory? 
(circle one number) 
 
 
Yes a Great Deal   Yes Somewhat  Only a Little  No, Not at All 







Circle one number for how often in the past 4 weeks you have had trouble remembering or how often this memory problem has 
interfered with your normal work or living.  
 
All of   Most of   A good bit   Some of   A little    None of   
   the time  the time   of the time   the time   of the      the time 
      
 
16. Trouble remembering things 
         people tell you      1      2           3             4           5              6  
 
 
The following questions are about CONCENTRATION problems you may have. Circle one number forr how often in the past 
four weeks you have had trouble concentrating or how often these problems have interfered with your normal work or living. 
 
 
All of   Most of   A good bit   Some of   A little    None of   
    the time  the time   of the time   the time   of the      the time 
               time  
 
17. Trouble concentrating on  1      2           3             4   5       6 
                 reading 
 
18.    Trouble concentrating  1      2           3             4   5       6
 on doing one thing at a time     
 








The following questions are about problems you may have with certain ACTIVITIES. Circle one number for how much during 
the past 4 weeks your epilepsy or anti-epileptic medication has caused trouble with…. 
 
 
All of   Most of   A good bit   Some of   A little    None of   
    the time  the time   of the time   the time   of the      the time 
                       time  
 
19. Leisure time   1      2           3             4             5            6 
 









Very     Somewhat   Not Very       Not Fearful 
  
            fearful   fearful        fearful             at all 
             
 
21. How fearful are you of      1                      2                   3        4 
                        having a seizure in the  
                        next month? 
 
       
 
      
 
Worry a lot Occasionally Worry              Don‘t Worry at all 
 
22. Do you worry about hurting          1   2   3 




     Very  Somewhat                 Not Very                Not at all 
               Worried Worried  Worried  Worried 
 
23. How worried are you about    1         2        3                 4  
               embarrassment or other social 
               problems resulting from having  
               a seizure during the next month? 
  
24. How worried are you that     1         2        3                 4  
               Medications that you are taking  
               will be bad for you if taken for a  




For each of these PROBLEMS circle one number for how much they bother you on a scale of 1 to 5 where 1 = not at all 
bothersome and 5 = extremely bothersome.  
 
     Not at all     Extremely 
     bothersome    bothersome 
 
25. Seizures        1   2          3                   4                   5 
 
26. Memory difficulties        1   2          3                   4                   5 
 
 
27. Work limitations        1   2          3                   4                   5 
 
28. Social limitations         1   2          3                   4                   5 
 
29. Physical effects of anti-epileptic       1   2          3                   4                   5 
                medication  
     
30. Mental effects of anti-epileptic       1   2          3                   4                   5 
                medication  
 
 
31. How good or bad do you think your health is? On the thermometer scale below, the best imaginable state 
of health is 10 and the worst imaginable state is 0. Please indicate how you feel about your health by circling one  
number on the scale. Please consider your epilepsy as part of your health when you answer this question.  
(Circle one number on the scale below) 
 
 
10 9 8 7 6 5 4 3 2 1 0 
Best Imaginable               Worst imaginable  































































































































































































































































































Distribution of Seizure Frequency 
 
SF
35.00
30.00
27.00
24.00
22.00
20.00
18.00
15.00
13.00
11.00
9.00
7.00
5.00
3.00
1.00
C
o
u
n
t
4.5
4.0
3.5
3.0
2.5
2.0
1.5
1.0
.5
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